cv part a february 2016

February 2016

CURRICULUM VITAE PART A

Personal Information:

Name: Jonathan Lester Finlay, M.B., Ch.B., F.R.C.P. (London),Business Address: Division of Hematology, Oncology and BMT,

Nationwide Children’s Hospital, 700 Children’s Drive, Room ED544, Columbus, OHIO 43205, USA

Business Phone: (614) 722-4087Business FAX: (614) 722-3369

Home Address: 6530 Plesenton Drive, Worthington, OH 43085

Home Phone: (614) 396-6307Mobile Phone: (614) 806-9844

Place of Birth: Manchester, England

Date of Birth: October 16th 1948

Citizenship: United States of America

E-mail Addresses [email protected] [email protected]

Education:

High School Carmel College, Wallingford, Berkshire, England 1957-1967

University The University of Birmingham, England B.Sc. Physiological Studies (Biochemistry) (Hons.) 1967- 1970

Medical School Birmingham University Medical School M.B., Ch.B. 1967- 1973

Internships Intern in General Surgery, City General Hospital, Stoke-on-Trent, England July-Dec 1973

Intern in Medicine, Queen Elizabeth Hospital, (Professorial Unit), University of Birmingham, England Head: Professor William Hoffenberg January- June 1974

Residencies Resident in Pediatrics, Birmingham Children's Hospital, England Head: Professor Charlotte Anderson Oncology Consultant: Dr. Jillian Mann

July 1974–Dec 1975

Resident in Pediatrics and Pediatric Oncology, The Christie Hospital, Manchester, England Director; Dr. Patricia Morris-Jones January –June 1976

- 1 -

mailto:[email protected]

mailto:[email protected]

Fellowships University of Wisconsin-Madison July 1976-June 1978 Pediatric Immunology Director: Dr. Richard Hong

University of Wisconsin-Madison July 1978-June 1980 Pediatric Hematology/Oncology Director: Dr. Nasarollah Shahidi

Medical Licensures: United Kingdom 07/1973 - 06/1976 (inactive)

Wisconsin 21434-20 02/03/78 - 12/31/87 (inactive) Pennsylvania MD038654E 06/02/87 - 05/31/ 2003 (inactive) New York 180561 10/27/89 - 09/30/2003 (inactive) Ireland 1997 – 2006 (1 month per annum) (inactive) California A35724 08/21/2003 – current (Certificate A35724)

Ohio 35-123679 06/15/2014 - current

Board Certifications:American Board of Pediatrics 1984

American Board of Pediatric Hematology/Oncology 1987

Extra-Mural Education:University of California-Davis Extension Course, Introduction to Enology & Viticulture 2005

Certificate in Enology & Viticulture, July 2005 - April 2008- Awarded with A grade

University of Birmingham, Alabama, School of Public Health, Sparkman Center for Global Health:

Certificate Course in Global Health, May 2009 - March 2011- Awarded with Distinction

Professional Background:

Academic Appointments:

Clinical Instructor in Pediatrics, Department of Pediatrics, University of Wisconsin-Madison, 1979-1980

Assistant Professor of Pediatrics, Department of Pediatrics, Division of Pediatric Oncology/Hematology, Stanford University, Stanford, California, 1980-1982

Assistant Professor of Pediatrics, Department of Pediatrics, Division of Pediatric Oncology and Hematology, University of Wisconsin-Madison, 1982-1985

Associate Professor of Pediatrics, Department of Pediatrics, Division of Pediatric Oncology and Hematology, University of Wisconsin-Madison, 1985-1987

Associate Professor, Department of Surgery, Division of Neurosurgery, University of Wisconsin- Madison, 1986-1987

Associate Professor of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, 1987-1989

Associate Member, Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York, 1989-1997

- 2 -

Associate Professor of Pediatrics, Cornell University Medical College, New York, 1989-1997

Professor of Pediatrics and Neurosurgery (with Tenure), New York University School of Medicine,New York, 1997-2003

The Julie and Edward J. Minskoff Chair of Pediatrics (Neuro-oncology), New York University School of Medicine, New York 2002-2003

Professor of Clinical Pediatrics (CHLA), Neurology and Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, 2003 – 2014

Audrey and Billy Wilder Endowed Chair in Neuro-oncology, The Children’s Hospital Los Angeles, 2012 – 2014

Professor of Pediatrics (with Tenure), The Ohio State University, Columbus, Ohio, 2014 – current

The Elizabeth and Richard Germain Endowed Chair in Pediatric Cancer, Nationwide Children’s Hospital, Columbus, Ohio, May 2015 - current

Clinical Administrative Appointments:

Staff Hematologist/Oncologist, Children's Hospital of Stanford, Stanford University, Stanford,California, 1980-1982

Attending Staff in Pediatrics and Pediatric Hematology/Oncology, University of Wisconsin Hospitals, Madison, Wisconsin, 1982-1986

Director, Mid-West Pediatric Neuro-Oncology Center, University of Wisconsin-Madison, 1983-1987

Medical Director of Pediatric Oncology, Department of Pediatrics, University of Wisconsin – Madison,1985-1987

Senior Physician, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania,1987-1989

Vice Chairman, Department of Pediatrics, Memorial Hospital, New York, 1989-1997

Associate Attending Pediatrician, Department of Pediatrics, Memorial Hospital, New York, 1989-1997

Associate Attending Pediatrician, Department of Pediatrics, New York Hospital, New York, 1990-1997

Interim Associate Clinical Director, Kaplan Comprehensive Cancer Center, New York UniversityMedical Center, New York, 1997-1998

Director, Division of Pediatric Oncology, New York University Medical Center, New York, 1997-2001

Director, Stephen D. Hassenfeld Center for Cancer and Blood Disorders of Childhood, New YorkUniversity Medical Center, New York, 1997-2003

Director, Neuro-oncology Program, The NYU Cancer Institute- New York University School of Medicine, New York, 2001-2003

Director, Neural Tumors Program, The Children’s Center for Cancer & Blood Diseases, the Children’sHospital Los Angeles, 2003 - 2014

Attending Neuro-oncologist, Norris Comprehensive Cancer Center, Keck School of Medicine,University of Southern California, 2004 – 2006

- 3 -

Consulting Neuro-oncologist, Pediatric Hematology/Oncology Division, Children’s Hospital of Oakland, 2006 – 2014

Clinical Director, Autologous Blood & Marrow Transplantation Program, Children’s Center for Cancer & Blood Diseases, Children’s Hospital Los Angeles, 2011 - 2014

Director, the Neuro-oncology Program, Division of Hematology, Oncology and BMT, Nationwide Children’s Hospital, Columbus, Ohio, 2014 - current

Honors, Awards and Citations:

British Medical Research Council (MRC) Award, Undergraduate Intercalated B.Sc. (Hons) Medical Student Program, 1969-1970

John Squire Memorial Fund Award, Medical Student Award, University of Birmingham, 1972

First Prize, Gourmet Section, Annual Wisconsin State Journal Cooking Competition, July 1977

Junior Faculty Clinical Fellowship, American Cancer Society, 1983-1986

American Society of Clinical Oncology annual meeting, Educational Workshop National Cancer Study Group presentations, invited speaker on behalf of the Children’s Oncology Group (COG), Houston, Texas, 1985

Outstanding Clinical Teacher Award by the Pediatric House Staff, University of Wisconsin Center for Health Sciences, Madison, Wisconsin, 1986-1987

Organizing Chair, First New York Regional Pediatric Hematologists/Oncologists Meeting, March 23rd

1991.

Organizing Chair and Speaker, Educational Symposium: Pediatric Brain Tumors. 4th Society of Pediatric Hematology/Oncology annual meeting, Chicago, Illinois, September 14th 1991

Invited Guest Speaker, 18th Annual Scientific Meeting of the Clinical Oncological Society of Australia (COSA), December 4-6th, 1991

Organizing Chair, Second New York Regional Pediatric Hematologists/Oncologists Meeting, March 8th

1992.

Organizing Chair, Educational Symposium, “Progress in childhood brain tumors." Annual Meeting of the American Society of Clinical Oncology (ASCO), San Diego, CA. May 1992.

Co-Chair and Speaker: CNS Germ Cell Tumor Session. Third International Neuro-oncology Conference, London, UK, April 19-20, 1993.

Advisory Board Member, 5th International Symposium on Pediatric Neuro-oncology (ISPNO), Marseilles, France, June 1993.

Citations in: "American Health” magazine, Best Doctors in America, 1994 - current

Citations in: "New York" magazine, Best Doctors in New York, 1994 – 2002

Citation in: Top Doctors: New York Metro Area, 3rd Ed 1999 – 7th Ed. 2003.

Member, Organizing Committee and Faculty, Sixth International Symposium on Pediatric Neuro-oncology, Houston, Texas, May 18-21, 1994

- 4 -

Keynote Speaker, 6th Canadian Neuro-oncology Meeting, Lake Louise, Alberta, CA, May 19-21st, 1994

Organizing Chair and Speaker, Educational Symposium: Current Issues in Childhood Brain Tumors. American Society of Pediatric Hematology/Oncology (ASPH/O) 9th annual meeting, Chicago, Illinois, September 1996

Chai LifeLine, Physician Recognition Award, 1998

Andrew Gargiso Foundation. First Annual Inspiration Recognition Award, 2000

Children’s Brain Tumor Foundation, Certificate of Appreciation Award, 2000

Society for Neuro-oncology, Award for Excellence in Pediatric Clinical Research, sponsored by the Pediatric Brain Tumor Foundation of the United States, Society for Neuro-oncology (SNO) annual meeting, Washington DC, November 2001

Keynote Lecture, 10th International Symposium of Pediatric Neuro-oncology (ISPNO), London, England. "High Dose Chemotherapy Strategies in the Management of Young Children with Malignant Brain Tumors", June 2002

Co-President, the First International Symposium on Central Nervous System Germ Cell Tumors, Kyoto, Japan, September 2003.

The Julie and Edward J. Minskoff Chair of Pediatrics (Neuro-oncology), New York University School of Medicine, New York, 2002-2003

Co-Chair (with Prof. Masao Matsutani), Session: Current Approaches to Germ Cell Tumors. 11th International Symposium on Pediatric Neuro-oncology (ISPNO), Boston, MA, June 16th 2004.

Co-Chair (with Drs. Chantal Kalifa, David Ashley and Russ Geyer), Session: CNS Tumors in Infants. 11th International Symposium on Pediatric Neuro-oncology (ISPNO), Boston, MA, June 16th 2004.

President, the Second International Symposium on Central Nervous System Germ Cell Tumors, Universal City, Los Angeles, November 2005

University of Southern California Mellon Academic Mentoring Support Program: Certificate of Recognition for Outstanding Mentoring, 2005.

Organizing Chair, International Workshop on Immunotherapy of Childhood Brain Tumors in the Setting of Minimal Residual Disease, Los Angeles, September 21st 2005

Co-Chair and Co-Organizer, First International Workshop on Myeloablative Chemotherapy and Autologous Hematopoietic Cell Rescue for Childhood Brain Tumors, Milan, Italy, September 2006.

Nominated, Children’s Hospital Los Angeles, 2006 Humanism Award

Organizing Chair, First International Workshop of Pediatric Neuro-oncology, Sao Paulo, Brazil, June 2007.

Organizing Chair, “Pediatric Malignant Gliomas” Mini-Symposium, 12th Annual Meeting of the Society for Neuro-oncology (SNO), Dallas, Texas, November 2007.

Scientific Board and Program Committee Member, 3rd Quadrennial Meeting of the World Federation of Neuro-oncology, Yokohama, Japan, May 2009

Organizing Chair, mini-Symposium on “Developing Management Strategies for children and adults with brain tumors in Low Income Countries”, 3rd Quadrennial Meeting of the World Federation of Neuro- oncology (WFNO), Yokohama, Japan, May 2009.

- 5 -

Organizing Co-Chair (with Dr. Hans Peter Wagner), mini-Symposium on “Developing management strategies for children with brain tumors in low income countries”, 41st Annual Congress of the International Society of Paediatric Oncology (SIOP), Sao Paulo, Brazil, October 2009

“Medical Visionary” Award (Presented by Dr. Larry Kun), Children’s Brain Tumor Foundation, West Coast Benefit Gala, Beverly Hills Hotel, October 22nd 2009

Nominated, Children’s Hospital Los Angeles, 2009 Humanism Award

International Organizing Chair, South American Pediatric Brain Tumor Symposium (Spanish language only), August 16th& 17th 2010, Asuncion, Paraguay

Grayson’s Gift Foundation, Achievement Award. November 11th 2010

Chair, Open Meeting of the International Outreach Committee, the 15th Annual Scientific Meeting of the Society for Neuro-oncology, Montreal, Canada, November 20th 2010.

Invited Moderator, Pediatric Plenary Session, 15th Annual Scientific Meeting of the Society for Neuro-oncology (SNO), Montreal, Canada, November 21st 2010.

Scientific Advisory Board Member, 2nd International Conference of the Society for Neuro-oncology/Pediatric Brain Tumor Foundation on Basic and Translational Pediatric Neuro-oncology, New Orleans, May 2011

Invited Co-Chair, Symposium: Innovative Multi-disciplinary Approaches to Minimizing Acute Symptoms and Late Effects in the treatment of CNS Tumours in Children. The 43rd Annual Congress of the International Society of Paediatric Oncology (SIOP), Auckland, New Zealand, October 27th 2011

Citation in: Guide to America’s Top Oncologists (Consumer Research Council of America), 5th Edition 2011

Citation in: Guide to America’s Top Pediatricians (Consumer Research Council of America), 6th, 7th and 8th

Editions, 2006, 2008 and 2011

Citation in: “US News and World Report” Top Doctors in the US, 2011 - current

Elected, Fellow of the Royal College of Physicians, London (F.R.C.P.), 2012

Member, International Organizing Committee, 15th International Symposium on Pediatric Neuro-oncology (ISPNO), Toronto, Canada, June 2012

Invited Co-Chair (with Dr. Irene Slavic), Rare Tumors Session, 15 th International Symposium on Pediatric Neuro-oncology (ISPNO), Toronto, Canada, June 2012

“We Can” Pediatric Brain Tumor Network Community Champion Award. Lakes at El Segundo, California, September 30th, 2012

Invited Chair, Brain Tumor Free Papers Session, 44 th Annual Congress of the International Society of Paediatric Oncology (SIOP), London, UK, October 2012

Society for Neuro-oncology, Award for Excellence in Pediatric Clinical Research, 17th Annual Meeting of the Society for Neuro-oncology (SNO), Washington DC, November 18th 2012

Audrey and Billy Wilder Endowed Chair in Neuro-oncology, The Children’s Hospital Los Angeles, 2013 - 2014

Member International Scientific Advisory Committee, the Third International Symposium on Central Nervous System Germ Cell Tumors, Cambridge University, UK. April 2014 Honoree, “Maddi’s Closet” Foundation First Gala, Whittier, California, July 19th 2013

- 6 -

Honoree, Chabad Los Feliz 15th Anniversary Gala, Hancock Park, Los Angeles, August 22nd 2013

Citation in: Top 10 Oncologists award, American Registry, 2013

Citation in: Los Angeles Top Doctors (Castle Connolly), 2013

Citation in: America’s Top Doctors for Cancer, (Castle Connolly) 2005 (1st Ed.) - 2014.

Citation in America’s Top Doctors (Top 1% of Sub-specialists) (Castle Connolly) from 8th (2009) to 13th (2014) editions).

Citation in: Best Doctors in America, (Best Doctors Inc.), - 2014

Member, External Scientific Advisory Board, City of Hope California Institute for Regenerative Medicine (CIRM)Grant: “Stem Cell-Mediated Therapy for High-Grade Glioma; Towards Phase I-II Clinical Trials”, 2009 – 2014

Invited Participant, The Pediatric Brain Tumor Research Landscape Think Tank: “Translating Discoveries to Cure the Kids”, San Antonio, Texas, May 14-15th 2014 Co-Chair (with Dr. Nalin Gupta), Pediatric Session 20th International Conference on Brain Tumor Research and Therapy, Lake Tahoe, California, July 2014

Citation in: Columbus Monthly, Top Doctors, November 2014

Citation in: Vitals Top 10 Doctors by State, 2014

Citation in: Patient’s Choice, 2010, 2011, 2014

Member, International Scientific Advisory Committee, the Fourth International Symposium on Central Nervous System Germ Cell Tumors, Tokyo, Japan, April 2015

Co-Chair (with Dr. Oren Becher), Brainstem and High-grade Gliomas Session, 4th Pediatric Basic and Translational Neuro-oncology Meeting, San Diego, California, Thursday May 7th 2015

Organizing Chair, Wyss Family Symposium on Genetic Predisposition to Nervous System Cancer, Columbus, Ohio, May 11th and 12th 2015

The Elizabeth and Richard Germain Endowed Chair in Pediatric Cancer, Nationwide Children’s Hospital, Columbus, Ohio, May 12th 2015 – current

Citation in: Compassionate Doctor, 2010, 2011, 2015

Citation in: Newsweek magazine Top Doctors for Cancer, 2015

Organizing Co-Chair, First Joint OSU/NCH/IPO UFSP Pediatric Neuro-oncology Conference, Sao Paolo, Brazil, August 31st – September 1st, 2015

Samuel Gross Memorial Lectureship, 2016: Honoree, University of Florida-Gainesville.

Specific Teaching Responsibilities:

Courses, Seminars :

Laboratory/Seminar Instructor, Second Year Medical Student Hematology Course, University of Wisconsin-Madison, 1982-1987

- 7 -

Pediatric Hematology/Oncology Fellows Seminar Course, Memorial Sloan-Kettering Cancer Center, 1989 - 1997

Pediatric Residents Seminar Course in Pediatric Oncology, New York University Medical Center, 1997 - 2003

Pediatric Hematology/Oncology Fellows Seminar Course, Children’s Hospital Los Angeles, 2003 - 2014

Medical Oncology Fellows’ Seminars, Norris Comprehensive Center, Univ. Southern California, 2003 - 2007

Neurosurgical Residents’ Seminars, Univ. Southern California, 2003- 2007

Instructor/Session Leader, Global Health Curriculum: CHLA IMPACT Residents’ Track, 2013 - 2014

Pediatric Oncology/Neuro-oncology Fellowship Trainees:

Children’s Hospital of Philadelphia:

Neuro-oncology Fellow, Dept. of Neurology, Children’s Hospital of PhiladelphiaEric Kramer, M.D. 1987-1988Current Position: Neurologist, Atlantis, Florida

Neuro-oncology Fellow, Dept. of Neurology, Children’s Hospital of PhiladelphiaBruce Cohen, M.D. 1988-1989Current Position: Professor of Neurology and Chief, Division of Child Neurology,Children’s Hospital of Akron, University of Akron-Ohio

Memorial Sloan-Kettering Cancer Center:

Neuro-oncology Fellow, Dept. of Neurology, Memorial Sloan-Kettering Cancer CenterMaritza Pons, M.D. 1989-1990

Neuro-oncology Fellow, Dept. of Neurology, Memorial-Sloan-Kettering Cancer CenterMeng Wong, M.D. 1990-1991Current Position: Chairman, Department of Neurology, Singapore General Hospital, Singapore

Neuro-oncology Fellow, Dept. of Neurology, Memorial Sloan-Kettering Cancer CenterIra Bergman, M.D. 1990-1991Current Position: Professor of Pediatric Neurology, University of Pittsburgh, and Chief, Child Neurology, Children’s Hospital of Pittsburgh, USA

Pediatric Neuro-oncology Visiting Fellow, Memorial Sloan-Kettering Cancer CenterPetra Reisinger, M.D., Homberg-im-Saar, Germany 1992

Pediatric Neuro-oncology Visiting Fellow, Memorial Sloan-Kettering Cancer CenterNasjla Saba Da Silva, M.D., 1992Current Position; Chief, Neuro-oncology Program, Universidade Federal de Sao Paolo and Pediatric Oncology Specialist, GRAACC, Sao Paolo, Brazil

Pediatric Neuro-oncology Visiting Fellow, Memorial Sloan-Kettering Cancer CenterRejin Kebudi, M.D., 1992Current Position: Professor of Pediatrics and Chief, Division of Pediatric Oncology, University of Istanbul Oncology Institute, Istanbul, Turkey

Pediatric Neuro-oncology Visiting Fellow, Memorial Sloan-Kettering Cancer CenterBlanca Diez, M.D., Buenos Aires, Argentina 1992Current Position: Director of Neuro-oncology, Institut FLENI, Buenos Aires, Argentina

- 8 -

Neuro-oncology Fellow, Dept. of Neurology, Memorial Sloan-Kettering Cancer CenterCasilda Balmaceda, M.D. 1992-1994Current Position: Neurologist and Neuro-oncologist, New York

Pediatric Neuro-oncology Visiting Fellow, Memorial Sloan-Kettering Cancer Center,Lucy Richard, M.D., Buenos Aires, Argentina 1993

Pediatric Neuro-oncology Visiting Fellow, Department of Pediatrics, Memorial Sloan-KetteringCancer Center, New YorkDiane Puccetti, M.D., University of Wisconsin-Madison 1993Current Position: Associate Professor of Pediatrics, Division of Pediatric Hematology/Oncology, University of Wisconsin-Madison, Wisconsin, USA

Pediatric Neuro-oncology Visiting Fellow, Memorial Sloan-Kettering Cancer CenterAnna Kurcysynski, M.D., Curitiba Children’s Hospital, Curitiba, Brazil 1993Current position: Attending Pediatric Oncologist, Curitiba Children’s Hospital,Curitiba, Brasil

Pediatric Neuro-oncology Fellow, Dept. of Pediatrics, Memorial Sloan-Kettering Cancer Center.Stephen Thompson, M.D. 1993-1994Current Position: Child Neurologist, University of Maryland, Baltimore, Maryland, USA

Clinical Assistant, Department of Pediatrics, Memorial Sloan-Kettering Cancer CenterIra Dunkel, M.D. 1993-1997Current Position: Director of Pediatric Neuro-oncology, Associate Member, Department of Pediatrics, Memorial Sloan-Kettering Cancer Center and Associate Professor of Pediatrics, Cornell Medical College, New York, USA

Pediatric Oncology Fellow, Department of Pediatrics, Memorial Sloan-Kettering Cancer CenterLawrence Faulkner, M.D. 1993-1994Current Position: Founder & Medical Coordinator, Cure2Children Foundation, Firenze, Italy

Pediatric Oncology Fellow, Department of Pediatrics, Memorial Sloan-Kettering Cancer CenterVasilios Papadakis, M.D. 1993-1994Current Position: Director of Pediatric Oncology, Aghia Sophia Children’s Hospital, Athens, Greece.Pediatric Oncology Fellow, Department of Pediatrics, Memorial Sloan-Kettering Cancer CenterDiane George, M.D. 1994-1995Current Position: Assistant Professor of Clinical Pediatrics, Columbia University. Attending Pediatric Hematology/Oncology-Bone Marrow transplantation, Morgan Stanley Children’s Hospital of NY/Presbyterian, New York

Pediatric Oncology Fellow, Department of Pediatrics, Memorial Sloan-Kettering Cancer CenterShraga Aviner, M.D. 1994-1995Current Position: Pediatric Hematology-Oncology, Ben Gurion University of the Negev, Israel

Pediatric Oncology Fellow, Dept. of Pediatrics, Memorial Sloan-Kettering Cancer CenterAfshan Ali-Nazir, M.D 1994-1995Current Position: Section Head, Pediatric Solid Tumors Service, King Faisal Specialist Hospital & Research Center, Ryadh, Saudi Arabia

Neuro-oncology Fellow, Department of Neurology, Memorial Sloan-Kettering Cancer CenterRon Freilich, M.D. 1994-1995Current Position: Staff Neuro-oncologist, Neuro-oncology Department, Monash University Medical

- 9 -

Center, Victoria, Australia

Neuro-oncology Fellow, Dept. of Neurology, Memorial Sloan-Kettering Cancer CenterWarren Mason, M.D. 1995-1996Current Position: Director, Neuro-oncology Program, Princess Margaret Hospital, Toronto, Ontario, Canada

Neuro-oncology Fellow, Dept. of Neurology, Memorial Sloan-Kettering Cancer CenterSubramanian Hariharan, M.D. 1995-1997Current Position: Staff Neuro-oncologist, New Jersey Neuroscience Institute, JFK Medical Center, Edison, New Jersey. Assistant Professor of Neuroscience, Seton Hall University School of Graduate Medical Education, South Orange, New Jersey

Clinical Assistant, Dept. of Pediatrics, Memorial Sloan-Kettering Cancer CenterSharon Gardner, M.D. 1995-1997Current Position: Director, Pediatric Bone Marrow Transplantation Service and AssociateProfessor of Pediatrics, New York University, New York, USA

Pediatric Oncology Fellow, Dept. of Pediatrics, Memorial Sloan-Kettering Cancer CenterMark Sapp, M.D. 1995-1997Current Position: Staff Pediatrician, Boston Children’s Hospital & Harvard Medical School

Pediatric Oncology Fellow, Dept. of Pediatrics, Memorial Sloan-Kettering Cancer CenterSri Gururangan, M.D. 1995-1997Current Position: Director, Pediatric Neuro-oncology Program and Professor of Pediatrics, University of Florida-Gainesville, Florida, USA

Pediatric Oncology Fellow, Dept. of Pediatrics, Memorial Sloan-Kettering Cancer CenterSuchitra Acharya, M.D. 1996-1997Current Position: Assistant Professor of Pediatrics, Division of Hematology/Oncology, New York Hospital-Cornell Medical College, New York, USA

Pediatric Oncology Fellow, Dept. of Pediatrics, Memorial Sloan-Kettering Cancer CenterShakil Modak, M.D. 1996-1997Current Position: Associate Member, Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, USA

Pediatric Neuro-oncology Visiting Fellow, Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New YorkFlorencia Moreno, M.D., Buenos Aires, Argentina 1996Current Position: Attending Pediatric Oncologist, Garrahan Children’s Hospital, Buenos Aires, Argentina

Pediatric Neuro-oncology Visiting Fellow, Dept. of Pediatrics, Memorial Sloan-Kettering Cancer CenterMichael Doubrovin, M.D., First Russian Children’s Hospital, Moscow, Russia. 1996-1997

Neuro-oncology Fellow, Dept. of Neurology, Memorial Sloan-Kettering Cancer CenterGiuseppe Stragliotto, M.D. 1996-1997Current Position: Attending Neuro-oncologist, Karolinska Institute, Stockholm, Sweden

Neuro-oncology Fellow, Dept. of Neurology, Memorial Sloan-Kettering Cancer CenterBrian Thiessen, M.D. 1996-1997Current Position: Neuro-oncologist, British Columbia Cancer Agency and University of British Columbia, Vancouver, British Columbia, Canada

- 10 -

Neuro-oncology Fellow, Dept. of Neurology, Memorial Sloan-Kettering Cancer CenterLauren Abrey, M.D. 1996-1997Current Position: Senior Medical Director, PDO at Roche Pharmaceuticals, Basel, Adjunct Professor, Department of Neurology at University of Zurich, Switzerland

New York University Medical Center:

Pediatric Neuro-oncology Visiting Fellow, Division of Pediatric Oncology, New York University School of Medicine Michael Doubrovin, M.D., Ph.D, First Russian Children’s Hospital, Moscow, Russia. 1997-1998Current Position: Associate Member, Diagnostic Imaging Department, Nuclear MedicineDivision, St. Jude Children’s Research Hospital, Memphis, TN

Pediatric Neuro-oncology Fellow, Division of Pediatric Oncology, New York University School of MedicineMark Sapp, M.D. 1997-1998Current Position: Assistant in Medicine, Complex Care Services, Staff Pediatrician, Boston Children’s Hospital and Harvard Medical School

Pediatric Neuro-oncology Fellow, Division of Pediatric Oncology, New York University School of MedicineBarkat Hooda, M.D., 1998-1999Current Position: Associate Professor of Pediatrics; Director, Division of Hematology-Oncology, University of Texas Medical Branch, Galveston, Texas

Pediatric Hematology/Oncology Research Fellow, Division of PediatricOncology, New York University School of MedicineKaren Moody, M.D. 2001-2002Current Position: Associate Professor of Pediatrics, Division of Hematology/Oncology, Riley Children’s Hospital and the University of Indiana,Indianapolis, IN

Pediatric Neuro-oncology Fellow, Division of Pediatric Oncology, New York University School of MedicineAlberto Broniscer, M.D. 2000Current Position: Associate Member, Neuro-oncology Division, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA

Pediatric Neuro-oncology Fellow, Division of Pediatric OncologyNew York University School of MedicineSusan Chi, M.D. 2000-2001Current Position: Assistant Professor of Pediatrics; Director, Pediatric Brain Tumors Clinical Trials Program, Pediatric Neuro-oncology Program, Dana Farber Cancer Institute, Boston Children’s Hospital and Harvard Medical School, Boston, Massachusetts, USA

Pediatric Neuro-oncology Fellow, Division of Pediatric Oncology,New York University School of Medicine Kavita Dhodapkar, M.D. 2000Current Position: Associate Professor of Pediatrics, Division of Pediatric Hematology/Oncology, Yale New Haven Medical Center, Yale University

Pediatric Neuro-oncology Laboratory Research Fellow, Division of Pediatric Oncology, New York University School of MedicineBirte Wistinhausen, M.D. 2001-2002

- 11 -

Current Position: Associate Professor of Pediatrics, Clinical Director of the Division of Pediatric Hematology/Oncology, Mount Sinai UniversitySchool of Medicine, New York

Visiting Neuro-oncology Fellow, Division of Pediatric Oncology, New York University School of MedicineFabio Ottaviano*, M.D., Neurologist, Buenos Aires, Argentina 2001-2002 (*deceased 2007)--------------------------------------------------------------------------------------------------------------------

Children’s Hospital Los Angeles:

Pediatric Hematology/Oncology Fellow, Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesVandana Batra, M.D. 2003-2004Current Position: Attending Oncologist, Division of Pediatric Oncology, Children’s Hospital of Philadelphia

Pediatric Neuro-oncology Fellow, Children’s Hospital Los AngelesMelissa Siegel, M.D. (Michael Hoefflin Foundation Fellow) 2004-2005 Current Position: Neuroscience Clinical Trials Division, Amgen, California

Pediatric Neuro-oncology Visiting Fellow,Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesDr. Andrea Capellano, University Federal of Sao Paolo, Brazil 2004Current Position: Neuro-oncology Program, Universidade Federal de Sao Paolo and Pediatric Oncology Specialist, GRAACC, Sao Paolo, Brazil

Pediatric Neuro-oncology Fellow, Children’s Hospital Los Angeles Jason Fangusaro, M.D. (Michael Hoefflin Foundation Fellow) 2005-2006Current Position: Associate Professor of Pediatrics; Director, Neuro-oncology Program, Children’s Memorial Hospital and Northwestern University, Chicago, Illinois, USA

Pediatric Neuro-oncology Fellow, Children’s Hospital Los AngelesGirish Dhall, M.D. (Michael Hoefflin Foundation Fellow) 2006-2007Current Position: Associate Professor of Pediatrics; Director, Neuro-oncology Program, Children’s Hospital Los Angeles and the University of Southern California

Pediatric Neuro-oncology Fellow, Children’s Hospital Los AngelesNeha Patel, M.D., (Michael Hoefflin Foundation Fellow) 2007-2008Current Position: Assistant Professor of Pediatrics, Pediatric Oncology Program,University of Wisconsin-Madison, Wisconsin, USA

Pediatric Neuro-oncology Fellow, Children’s Hospital Los AngelesSoumen Khatua, M.D. 2008-2009Current Position: Associate Professor of Pediatrics, Section Chief of the Neuro-oncology Program, MD Anderson Cancer Center, Houston, Texas

Pediatric Neuro-oncology Visiting Fellow, Children’s Hospital Los Angeles.Patricia Scharffenberger, Hospital Italiano, Buenos Aires, Argentina August 2008Current Position: Chief of Pediatric Oncology Section, Hospital Italiano,Buenos Aires, Argentina

- 12 -

Pediatric Neuro-oncology Fellow, Children’s Hospital Los AngelesRobert J. Brown, M.D. 2009-2010Current Position: Clinical Research Instructor, Assistant Attending in Pediatrics, Children’s Hospital Los Angeles

Pediatric Oncology/International Outreach Fellow, Children’s Hospital Los AngelesJacquelyn Baskin, M.D. 2008-2011Current Position: Assistant Professor of Pediatrics, Children’s Center for Cancer & Blood Diseases, Children’s Hospital Los Angeles

Pediatric Neuro-oncology Visiting Fellow, Children’s Hospital Los AngelesVeronica Kim, M.D., Pediatric Oncology,Hospital Maternal Y Infantil, Asuncion, Paraguay June-July 2010

Pediatric Neuro-oncology Senior Fellow, Children’s Hospital Los AngelesRobert J. Brown, M.D. 2010-2013Current Position: Post-doctoral Research Fellow, UC-Los Angeles Clinical Attending in Pediatrics, Children’s Hospital Los Angeles

Pediatric Neuro-oncology Fellow, Children’s Hospital Los AngelesTom Belle Davidson, M.D. 2010-2011Current Position: Assistant Professor Pediatrics, Chief, Pediatric Neuro-oncology Program, Mattel Children’s Hospital, UC-Los Angeles, CA

Pediatric Neuro-oncology Fellow, Children’s Hospital Los Angeles 2011- 2012Wafik Zaky, MD. (St.Baldrick’s Fellowship Research Grant)Current Position: Assistant Professor of Pediatrics, Neuro-oncology Program, MD Anderson Cancer Center, Houston, Texas 2012- current

Pediatric Oncology Visiting Fellow, Children’s Hospital Los Angeles 2011-2012Andreeza Senerchia, M.D.Current Position: Oncology Program, Universidade Federal de Sao Paolo and Pediatric Oncology Specialist, GRAACC, Sao Paolo, Brazil

Pediatric Hematology-Oncology Fellow, Children’s Hospital Los Angeles 2011-2013Rajkumar Venkatramini, M.D.Current Position: Assistant Professor of Pediatrics, Texas Children’s Hospital,Baylor College of Medicine, Houston, TX

Pediatric Hematology-Oncology Fellow, Children’s Hospital Los Angeles 2011-2013Reuben Anthony, M.D. Current Position: Assistant Professor of Pediatrics, University of Illinois, Peoria, IL

Pediatric Hematology-Oncology Fellow, Children’s Hospital Los Angeles 2011-2013Hung Tran, M.D.Current Position: Assistant Professor of Pediatrics, Children’s Center for Cancer & Blood Diseases, Children’s Hospital Los Angeles

Pediatric Neuro-oncology Fellow, Children’s Hospital Los Angeles 2012-2013Jhon Guerra, M.D., (Michael Hoefflin Foundation Fellow)Current Position: Chairman, Department of Pediatrics, Director, Pediatric Oncology and BMT Program, HIMA San Pablo Caguas Hospital, San Juan, PR

Pediatric Neuro-oncology Fellow, Children’s Hospital Los Angeles 2013-2014

- 13 -

Ashley Margol, M.D., (Michael Hoefflin Foundation Fellow)Current Position: Assistant Professor of Pediatrics, Neuro-oncology Program, Children’s Center for Cancer & Blood Diseases, Children’s Hospital Los Angeles

Nationwide Children’s Hospital:

Scott Coven, MD, Pediatric Hematology-Oncology Fellow, Nationwide Children’s Hospital. Clinical research project for MPH 2014+

Pre-Medical Student/Medical Student/Graduate/Resident Trainees:

Undergraduate Research Advisor, University of Wisconsin-MadisonJeffrey Toretsky (Pre-Med. Student) 1982-1984Current Position: Professor of Pediatrics, Division of Pediatric Hematology/Oncology, Georgetown University/Lombardi Cancer Center, Washington DC

Undergraduate Research Advisor, University of Wisconsin-MadisonJudith Knipple (Pre-Med Student) 1985-1986Current Position: Medical Internist, Arlington Heights, Illinois

Summer Student Research Assistantships, New York University: Leila Neruddin, 2nd Year Med. Student (New York University) 1998Lisa Golumb, 4th Year Med. Student (New York University) 1998Cathy Pietanza, 2nd Year Med. Student (Downstate, State University of New York) 1998

Student Research Assistantships, New York University:Theo Nicholaides, 3rd Year Med. Student (New York University) 1999-2000Current Position: Assistant Professor of Pediatrics, Division of Pediatric Oncology, University of California-San Francisco, USA

Student Research Assistantship, New York University:Gregor Drucker, 4th Year Medical Student (University of Bonn, Germany) 2000Current Position: Consultant Pediatric Immunologist and Rheumatologist, HELIOS Klinikum Krefeld Children’s Hospital,Academic teaching hospital of RWTH, Aachen, GermanyHayden Boyce, 3rd Year Med. Student (New York University) 1999-2000

Pediatric Neurology Resident Research Elective, Dept. of Neurology,New York University School of MedicineDewi Depositario, M.D. 2001-2002

Pediatric Resident Clinical Research Elective, Division of Pediatric Oncology,New York University School of MedicineDennis Kuo, M.D. 2001-2003Current Position: Assistant Professor of Pediatrics, Pediatric Oncology Program, Rady Children’s Hospital, UC-San Diego, CA, USA

Student Clinical Research Assistantship, Division of Pediatric Oncology:Hank Aaron, 3rd year Med. Student, Sackler Univ. School of Medicine, Israel 2002Lindsay Norris, 3rd Year Pre-Med. Student, Princeton University 2002Claire Constantine, 2nd Year Pre-Med. Student, Univ. Pennsylvania 2002

Pediatric Resident research Elective, Division of Pediatric Oncology, New York University School of MedicineSung W. Choi, M.D. 2001-2002

- 14 -

Current Position: Assistant Professor of Pediatrics, Division of Bone Marrow Transplantation, Mott Children’s Hospital,University of Michigan-Ann Arbor, MI

Pediatric Resident, Research Elective, Division of Pediatric Oncology,New York University School of MedicineAeRang Kim, M.D., Ph.D. 2002-2003Current Position: Assistant Professor of Pediatrics, Division of Pediatric Oncology, DC National Children’s Medical Center, Washington DC, USA

Student Clinical Research Assistantship, Division of Pediatric Oncology,New York University School of MedicineMatthew Visser, 3rd Year Pre-Med Student, Univ. of N. Carolina, Chapel Hill 2002-2003

Senior Med. Student Research Assistantship, Division of Pediatric Oncology,New York University School of MedicineJames Weisfeld-Adams, Final Year Medical Student, University of Aberdeen, Scotland 2002-2003Current Position, Adjunct Assistant Professor, Genetics and Genomic Sciences, Division of Genetics, Mount Sinai School of Medicine, New York

Pediatric Resident Research Elective, Neural Tumors Program,Children’s Hospital Los AngelesStephanie Heller, M.D. 2004-2006

Pediatric Resident Research Elective, Neural Tumors Program,Children’s Hospital Los AngelesGuy Efron, M.D. 2004-2006

Pediatric Resident Research Elective, Neural Tumors Program, Children’s Hospital Los AngelesArti Nasta, M.D. 2004-2006

Medical Student Summer Oncology Fellow, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesEmily Shiver. Drexel University, Pennsylvania 2004

Medical Student Summer Oncology Fellow, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesDiana Osorio. 2004Current Position: Assistant Professor of Pediatrics, Neuro-oncology Program, Nationwide Children’s Hospital and The Ohio State University, Columbus, OH

Pre-Med Student Summer Research Elective, Neural Tumors Program, Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesJulia Dilday, University of California – Berkeley 2004

Pre-Medical Student Summer Research Elective,Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesLisa Saud, University of Uberaba, Uberaba, M.G., Brazil 2004

Medical Student Summer Oncology Fellow, Neural Tumors Program, Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesMonirat Saly, 2nd Year Medical Student, University of Nevada-Reno 2005

Medical Student Summer Oncology Fellow, Neural Tumors Program, Division of Pediatric Hematology/Oncology, Children’s Hospital Los Angeles

- 15 -

Anjali Gopalan, 2nd Year Medical Student, Washington University St. Louis 2005

Medical Student Research Elective, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesYvonne Chiu, 4th year Medical Student, USC/Keck School of Medicine 2005

Medical Student Summer Research Elective, Neural Tumors ProgramDivision of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesCourtney Sherman, 2nd Year Med. Student, NY Med. College, Valhalla, NY 2006

Pre- Medical Student Summer Oncology Research Elective, Neural Tumors Program, Division of Pediatric Hematology/OncologyChildren’s Hospital Los AngelesDanielle Kochavi , Undergraduate student 2006

Medical Student Summer Oncology Fellow, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesZacharey Seymour, 2nd Year Medical Student, Washington University St. Louis 2006

Pre-Medical Student Summer Research Elective, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesSally Kate Bovensiepen B.Sc. (Hons), Cambridge University, England 2006

Pre-Medical Student Research Elective, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesAlexa Gozali, USC/Keck School of Medicine 2007- 2010

Medical Student Research Elective, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesKatie Serowka, 3rd year Med. Student, USC/Keck School of Medicine 2007- 2009

Pre-Medical Student Research Elective, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesAdam Showman, Nottingham University, England 2007

Medical Student Research Elective, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los Angeles 2007- 2008Ronald Tang, 4th Yr. Medical Student, Western Osteopathic Medical School, California

Pre-medical Student Research Elective, Neural Tumors ProgramDivision of Pediatric Hematology/Oncology, Children’s Hospital Los Angeles,Stephanie Si, Pepperdine University, Malibu, California 2008-2009

Medical Student Summer Oncology Fellow, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesJaimin Amin, 2nd year medical student, University of Chicago 2008

Medical Student Summer Oncology Fellow, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesRuby Hirmaneck, 2nd year medical student, Wayne state University 2008

Pre-medical Student Summer Research Elective, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesAlbert Jacob, University of Nottingham, England 2008

Pre-medical Student Summer Research Elective, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los Angeles

- 16 -

Liora Pollick, University of Pennsylvania, Philadelphia 2008

Pre-medical Student Summer Research Elective, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesAllan Lavian, UC-Santa Barbara 2008

Pediatric Resident Research Elective, Neural Tumors Program, Children’s Hospital Los AngelesRebecca Stahl, M.D. 2008-2010

Pre-medical Student Research Elective, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los Angeles,Jennifer Dagri, UCLA 2010- 2013

Medical Student Summer Oncology Fellow, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los Angeles,Nicole Flores, UC-Irvine 2010

Medical Student Summer Oncology Fellow, Neural Tumors Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los Angeles,Hussain Rahem, UMD-NJ 2010

Sarah Kreimer, MD, Pediatric Intern Elective, LA County-USC, Los Angeles 2010-2011

Juan Espinoza, MD, Pediatric Intern Elective, Children’s Hospital Los Angeles 2011-2012

Medical Student Summer Oncology Fellow, Neuro-oncology ProgramDivision of Pediatric Hematology/Oncology, Children’s Hospital Los AngelesClaire Belessiotis, King’s College, London, UK 2012

Alison Yin Liu, MD, PhD, Clinical Research Elective (MD PhD Program), 2012-2014University of Southern CaliforniaCurrent Position: Pediatric resident, Loma Linda University

Nicholas P. Giustini, B.S. 2nd – 3rd Year Medical Student Research Scholarly Project (RSP), Keck School of Medicine, University of Southern California 2012-2014

Medical Student Summer Oncology Fellow, Neuro-oncology Program,Division of Pediatric Hematology/Oncology, Children’s Hospital Los Angeles,Sarah Inman, 2nd Year Medical Student, University of Ohio Medical School-Toledo 2013-2014Rachel Pruitt, 2nd Year Medical Student, North Shore University Medical School, NY 2013-2014

Courtney Altshuler, BS,Medical Student Clinical Research Elective, University of Southern California 2013-2014

Ann Cochrane, BS Pre-Medical Student Clinical Research Elective, University of Southern California 2013-2014

Ross Mangum, MD, 1st year Pediatric resident, Nationwide Children’s Hospital.Clinical research elective project 2015+

Bethany Brisbin, MD, 2nd year Med/Pediatrics resident, Nationwide Children’s Hospital.Clinical research elective project 2015

Specific University or Hospital Administrative Responsibilities:

- 17 -

Director, Mid-West Pediatric Neuro-Oncology Center, University of Wisconsin-Madison, 1983-1987

Medical Director of Pediatric Oncology, Department of Pediatrics, University of Wisconsin – Madison, 1985-1987

Vice Chairman, Department of Pediatrics, Memorial Hospital, New York, 1989-1997

Member, Institutional Review Board, Memorial Sloan-Kettering Cancer Center, 1993-1997

Interim Associate Clinical Director, Kaplan Comprehensive Cancer Center, NYU Medical Center, 1997-1998

Member, Kaplan Comprehensive Cancer Center Executive Committee, NYU Medical Center, 1997-2003

Director, Division of Pediatric Oncology, NYU Medical Center, New York, 1997-2001

Director, Stephen D. Hassenfeld Center for Cancer and Blood Disorders of Childhood, New York University Medical Center, New York, 1997-2003

Director, Neuro-oncology Program, The NYU Cancer Institute- New York University School of Medicine, New York, 2001-2003

Clinical Director, Neural Tumors Program, Children’s Center for Cancer & Blood Diseases, Children’s Hospital of Los Angeles, 2003 – 2012

Member, Fellowship Committee, Children’s Center for Cancer and Blood Diseases,Children’s Hospital Los Angeles, 2004 – 2014

Interim Clinical Director, Autologous Blood & Marrow Transplantation Program, Children’s Hospital Los Angeles, 2011-2013

Faculty Member & Mentor, CHLA Global Health IMPACT Residency Track ProgramChildren’s Hospital Los Angeles, 2013 - 2014

Director, Neuro-oncology Program, Children’s Hospital Los Angeles, 2012 – 2014

Director, Neuro-oncology Program,Nationwide Children’s Hospital, 2014 - current

Director, Neuro-oncology Fellowship Training Program,Nationwide Children’s Hospital, 2014 - current

Member, Graduate Medical Education Committee,Nationwide Children’s Hospital, 2014 - current

Member, Promotion & Tenure Committee,Nationwide Children’s Hospital, 2015- current

Full Member, James Comprehensive Cancer Center,The Ohio State University, Columbus, OH

Doctoral Thesis Committee:

Doctor in Medical Sciences Thesis: External Examiner/Juror,Catholic University of Leuven, Belgium, Faculty of Medicine, Laboratory of Experimental Immunology, Department of Neurosurgery.Steven De Vleeschouwer, M.D.“Autologous dendritic cell-based vaccine against malignant gliomas: pre-clinical

- 18 -

and clinical development”. 2004-2005

Military Service:

None

Government Activities:

None

Community/Professional Service:

Member, Medical Advisory Board, The Marcus Foundation, 1991 - 2000

Member, Medical Advisory Board, The Mitchell Ross Children’s Cancer Fund, 1991 - 2005

Member, Medical Advisory Board, Children’s Brain Tumor Foundation, 1995 - current

Camp Physician, Barretstown Gang Camp (for children with cancer and blood disorders), Kildare, Ireland, August 1997

Chairman, Medical Advisory Board, Katie’s Kids for the Cure (The National Fund for Children’s Brain Tumor Research), 1998 - 2008


Chairman, Medical Advisory Board, Andrew J. Gargiso Foundation (for Burkitt’s Lymphoma/Leukemia), 1998 – 2003

Medical Co-Director, Medical Advisory Board, Children’s Brain Tumor Foundation, 2000 – current


Organizing Chair, Neurofibromatosis Families Workshop, Children’s Hospital Los Angeles, December 4th 2004

Medical Advisory Board, Young Children Cancer Foundation of America, 2004- 2014

Camp Physician, Annual We Can Camp for Children with Brain Tumors and Their Families, Idylwild, CA, Fall 2004 - 2013

Chairman, Medical Advisory Board, Maddi’s Closet Foundation, 2005- 2014

Medical Advisory Board, Matthew Larsen Children’s Brain Tumor Foundation, 2007 – current

American Academy of Pediatrics, PREP Hematology-Oncology Advisory Board, 2009 - 2010

Soccer For Kids, Annual Gala Event, Laguna Beach, CA, October 11th 2014 -invited speaker

Children’s Champion: Ran the Columbus Half-marathon, October 19th 2014, raising approx. $6,000 for Nationwide Children’s Hospital

Ride for Kids, Pediatric Brain Tumor Foundation Starlight 5 K run, Marysville Ohio July 10th 2015 -ran 5K and speaker at after event.

Ride for Kids, Pediatric Brain Tumor Foundation, Marysville, Ohio, July 11th 2015 - event speaker.

- 19 -

Soccer For Kids, Annual Gala Event, Laguna Beach, CA, October 24th 2015 - invited speaker

Children’s Champion: Ran the Columbus Half-marathon, October 18th 2015, organized the “Brain Gang” Team, raising just over $10,000 for Nationwide Children’s Hospital

Editorial Positions:

1983+ Ad hoc Reviewer , American Journal of Pediatric Hematology/Oncology, Journal of the National Cancer Institute, The Journal of Pediatrics, Journal of Clinical Oncology, Cancer, Clinical Pediatrics, New England Journal of Medicine, Cancer Chemotherapy and Pharmacology, Journal of Neuro-oncology, Medical and Pediatric Oncology, European Journal of Cancer, Clinical Cancer Research, Bone Marrow Transplantation, Pediatric Blood and Cancer, Neuro-oncology, Journal of Pediatric Hematology and Oncology, Nature Reviews-Neurology.

2015-2016 Ad hoc Reviewer: Pediatric Blood & Cancer, J Transplantation, J Pediatric Hematology & Oncology, PLOS One, Neuro-oncology,

1983-1987 Reviewer, US Pharmacopeia - Dispensing Information (USP-DI)

1988-1991 Consulting Reviewer, ICRDB Cancergrams, "Pediatric Oncology" and "CNS Malignancies"

1989- current PDQ Extramural Board Reviewer - Childhood Brain Tumors

1991-1999 Editorial Board: "Critical Reviews in Neurosurgery"

1993-2001 Editorial Board: "Child's Nervous System"

2003 – current Editorial Board: “Neuro-oncology”

2007 – current Editorial Board: “Pediatric Rehabilitation Medicine”

2014 - current Editorial Board: “Pediatric Neurology”

2015- current Editorial Board: “Pediatric Blood and Cancer”

Committee Memberships:

National/International:

Children’s Cancer Group: Member, High-stage Medulloblastoma Committee (CCG-921), 1983-1999 (final publication date)

Children’s Cancer Group: Member, Low-stage Medulloblastoma Committee (CCG-923), 1984-2000 (final publication date)

Children’s Cancer Group: Chairman, Malignant Glioma Committee (CCG-945), 1984- 2015 (final publication date)

Children’s Cancer Group: Chairman, Brain Tumor Strategy Group, 1985-1992

Children’s Cancer Group: Member, Brain Tumor Biology Committee, 1985-1988

Children’s Cancer Group: Chairman, Poor-Risk Non-Lymphoblastic Lymphoma Committee(CCG-552), 1985- 1994 (final publication date)

- 20 -

Children’s Cancer Group: Member, Recurrent Non-Hodgkin's Lymphoma Committee(CCG-5001), 1985-1988

Children’s Cancer Group: Chairman, Autologous Bone Marrow Transplantation in Recurrent Brain TumorsCommittee, (CCG-9883), 1986-2008 (final publication date)

Children’s Cancer Group: Member, Ependymoma Committee (CCG-9442), 1988-2012(final publication date)

American Society of Pediatric Hematology & Oncology, Member, Nominating Committee, 1988-1989

Facilitator and Reviewer, Int. Society of Pediatric Oncology, (SIOP) Brain Tumor Committee, 1989-1990

Children’s Cancer Group: Vice-Chairman, Third Party Payment Committee, 1988-1992

Children’s Cancer Group: Member, Baby Brain Tumor Committee (CCG-9921), 1989-2005 (final publication date)

Children’s Cancer Group: Chairman, Autologous Bone Marrow Transplantation in Newly-diagnosed High-grade Astrocytoma (CCG-9922), 1990-1999 (final publication date)

Children’s Cancer Group: Steering Committee, Brain Tumor Strategy Group, 1992-1999

Member, Autologous Bone Marrow Transplantation Registry, Pediatrics Committee, 1995 - current

Children’s Cancer Group: Chairman, Lymphoma Strategy Group, 1996-2000

Chair, Brain Tumor Study, Autologous Bone Marrow Transplantation Registry, 1998-2002

Member, Brain Tumor Transition Committee, Children’s Cancer Group and Pediatric Oncology Group,1998-2002

Co-Chair, Non-Hodgkin’s Lymphoma Transition Team, Children’s Cancer Group and Pediatric Oncology Group, 1999-2000

Vice Chair, CCG-L991 Long Term Follow-up Study for Malignant Glioma Survivors on CCG-945, 2002-2012(final publication date).

Member, Brain Tumor Steering Committee, Children’s Oncology Group, 2002 - current

Co-Chair, High Grade Glioma Studies, Brain Tumor Steering Committee, Children’s Oncology Group, 2002 – 2005

Member, ACNS 0231 (Recurrent Malignant Glioma) Committee, Children’s Oncology Group, 2002 – 2006

Member, COG-99703 Young Children with Malignant Brain Tumors Committee, 1997- 2015 (final publication date)

Member, City of Hope Cancer Center CIRM Grant External Scientific Advisory Board“Stem cell mediated therapy for high grade glioma: toward phase I-II clinical trials”, 2008- 2014

Member, American Academy of Pediatrics PREP Hematology-Oncology Advisory Board, 2009- 2010

Site Co-investigator, Children’s Hospital Los Angeles, Department of Defense-funded Neurofibromatosis Clinical Trials Consortium, December 2011- 2014

Site Co-Principal Investigator, Children’s Hospital Los Angeles, NIH-funded Pediatric Brain Tumor Consortium (PBTC), January 2012- 2014

- 21 -

Site Co-Principal Investigator, Children’s Hospital Los Angeles CERN (Ependymoma) Consortium, January 2012 – 2014

Site Co-Principal Investigator, Children’ Hospital Los Angeles, Pacific Pediatric Neuro-oncology Consortium (PNOC), 2012 – 2014

Co-Chair, Pediatric Neuro-oncology Working Group, The Ohio Clinical Trials Collaborative, 2014 - current

Site Principal Investigator, Nationwide Children’s Hospital, Pacific Pediatric Neuro-oncology Consortium (PNOC),2015- current

Professional/Academic Society Memberships & Appointments:

National:

American Society of Pediatric Hematology/Oncology 1985 (current) American Society of Clinical Oncology 1986 (current) American Association for Cancer Research 1989 (lapsed) Brain Tumor Club Chair, Los Angeles 2007American Society of Hematology 1992 (lapsed)American Academy of Pediatrics 1986 (lapsed)British Neuro-oncology Society 2015 (current)

International:

International Society of Experimental Hematology 1980 (lapsed) International Society of Paediatric Oncology (SIOP) 1987 (current) Society for Neuro-Oncology 1994 (current) Chair, International Outreach Committee 2006 - 2011 Pediatric Member, Executive Board 2006 - 2011

American Society for Blood and Marrow Transplantation 1994 (lapsed) International Bone Marrow Transplantation Registry/Autologous Bone Marrow Transplantation Registry (IBMTR/ABMTR) 1994 (lapsed) Histiocyte Society 1995 (lapsed)

Loco-Regional:

Central Ohio Pediatric Society (COPS) 2015 (current)Ohio State University Faculty Club 2015 (current)

Research and Philanthropic Grants ( since 1985 ):

1985-1986 University of Wisconsin Medical School Research Committee. Development of human and canine brain tumor clonogenic assays in vitro. $10,000

1986-1987 Lederle Laboratories (American Cyanamid Company). Pharmacokinetic studies of Thiotepa following delivery by various routes. $ 5,000

1987-1990 Doris Gates Rankin Trust Award, $3,000 p.a.3 years. P.I.s: Jonathan L. Finlay, M.B., Ch.B. and Sheldon A. Steinberg, V.M.D.,

- 22 -

School of Veterinary Medicine, University of Pennsylvania. “Pharmaco-kinetics of Thiotepa in endogenous tumor-bearing canines”. $ 9,000

1993-1994 The Society of Memorial Sloan-Kettering Cancer Center. P.I.: Jonathan Finlay. “A Feasibility Study of Chemotherapy without Irradiation in the Treatment of Young Children with Newly-diagnosed Malignant Brain Tumors". $ 49,666

1994-1995 The Children's Brain Tumor Foundation , P.I.: Jonathan Finlay. “An International Collaborative Study of Primary

Central Nervous System Germ Cell Tumors of Childhood and Adolescence". $20,000

1996-1997 Children’s Cancer Study Group, Strategy Group Chairman’s Grant (sub-grant from N.C.I.) $ 2,000



1999-2002 Hasbro Children’s Foundation. Behavioral Health Program Development. P.I., Jonathan Finlay. $436,000

1999-2002 The Mitchell Ross Children’s Cancer Fund. Two clinical research grants for “Head Start II” protocol and “The 3rd International CNS Germ Cell Tumor Study” protocol.P.I., Jonathan Finlay. $130,000

1999-2000 The Children’s Cancer Foundation. Development Grant to the Hassenfeld Children’s Cancer Center. P.I., Jonathan Finlay. $113,000

2000-2001 The Children’s Cancer Foundation. Development Grant to the Hassenfeld Children’s Cancer Center. P.I., Jonathan Finlay. $123,000

2001-2002 Kids for NYU Grant. “3rd International CNS GCT Study”. P.I., Jonathan Finlay. $ 25,000

2001-2002 Ilma Kern Foundation. Support of Institutional Neuro-oncology Studies.P.I., Jonathan Finlay. $ 25,000

2001-2002 The Children’s Cancer Foundation Development Grant to the Hassenfeld Children’s Cancer Center. P.I., Jonathan Finlay. $139,000

2002-2003 Kids for NYU Grant. “Third International CNS GCT Study”. P.I., Jonathan Finlay. $ 12,500

2002-2003 Brain Tumor Foundation of the United States: The Andrew Christian Bryce Foundation Award. “Quality of Life and Functioning of Survivors of Young Children with Medulloblastoma/PNET on Head Start II

Protocol”: Co-P.Is.: Stephen Sands and Jonathan Finlay. $ 50,000

2004-2005 Michael Hoefflin Brain Tumor Foundation, Pediatric Neuro-oncology Fellowship Program. P.I., Jonathan Finlay. $ 80,300

- 23 -

2004-2005 Michael Hoefflin Brain Tumor Foundation, Head Start Glioma Protocol,Principal Investigator, Jonathan Finlay. $ 60,043


2005-2006 Michael Hoefflin Brain Tumor Foundation, Head Start Glioma Protocol, P.I., Jonathan Finlay. $ 60,280

2005-2006 Michael Hoefflin Brain Tumor Foundation, Head Start Protocol Neuropsychological Outcome. P.I, Jonathan Finlay & Sharon O’Neil. $ 46,000

2005-2006 Martell Foundation CHLA Brain Tumor Research Award Co-investigator, 5% effort. $ 11,684

2006 Soccer for Hope Foundation $ 25,000

2006 California Community Foundation $ 90,000

2006 From Maddi’s Closet Foundation $ 4,500


2006-2007 Michael Hoefflin Brain Tumor Foundation, Head Start Glioma Protocol, P.I., Jonathan Finlay. $ 60,280

2006-2007 Martell Foundation CHLA Brain Tumor Research Award Co-investigator, 5% effort.

2006-2009 Pediatric Brain Tumor Foundation Pre-Institute Award. Co-P.I., $100,000 per annum x 3 years $300,000

2007 Soccer for Hope Foundation $250,000

2007 Rags for Riches Foundation $ 5,000


2007-2009 Alex’s Lemonade Stand. Clinical Research Program Award in Childhood Cancer. P.I., Jonathan Finlay. $125,000 per annum x 2 years $250,000


2007-2008 St. Baldrick´s Foundation, Clinical Research Award. Neuropsychological outcome for childhood brain tumor survivors.

P.I., Jonathan Finlay $ 50,000



2008-2009 Michael Hoefflin Brain Tumor Foundation, Pediatric Neuro-oncology Fellowship Program. P.I., Jonathan Finlay. (50% funding) $ 76000

2008-2011 Pediatric Cancer Research Foundation (PCRF) Grant.

- 24 -

P.I. Jonathan Finlay. $185,000

2008-2010 Childhood Brain Tumor Foundation GrantRecurrent CNS Germ Cell Tumor Phase I/II Consortium P.I. Jonathan Finlay $25,000 per annum x 2 years $ 50,000


2010 International Union Against Cancer (UICC) Spanish-speaking Symposium on Childhood Brain Tumors, Asuncion, Paraguay, August 16th& 17th 2010 Organizing Chair: Jonathan Finlay $ 3,600

2010 Jenny’s Quest (Brainstem Glioma) Research Foundation $ 10,000



2011-2012 St. Baldrick’s Foundation, Pediatric Neuro-oncology Fellow (Dr. Wafik Zaky). P.I., Jonathan Finlay. $ 83,000

2011 Jenny’s Quest (Brainstem Glioma) Research Foundation $ 10,000




2012 Irma Rudd Foundation $ 28,000

2012-2013 Michael Hoefflin Brain Tumor Foundation, Pediatric Neuro-oncology Fellowship Program. P.I., Jonathan Finlay. (65% Funding) $ 55,000


2013 The Brad Kaminsky Foundation $ 14,400

2013 Michael Hoefflin Brain Tumor Foundation, Pediatric Neuro-oncology Fellowship Program. P.I., Jonathan Finlay. (50% Funding) $ 40,000

2013 National Cancer Coalition Angel Grant $ 7,000 In support of the “Head Start” Consortium, PI: Jonathan Finlay


04/01/2015 – 03/31/2020. R01 NCI Co-Principal Investigator. Adoptive Immunotherapy for Recurrent Pediatric High-grade Gliomas

06/01/2015 – 05/31/2020 R01 NINDS Co-Investigator. A Novel STAT3-Selective Inhibitor for Meduloblastoma Therapy.

$340,635 (Total)2015 (May) Soccer for Hope Foundation. For support of Wyss Family Symposium on Genetic Predisposition to Brain Cancer. $ 35,000

- 25 -

2015 (July) NCH NEXT Consortium, for support of the Head Start 4 Trial, $215,000/year x 5 years $1,075,000 (Total)

Principal Investigator, Investigator-Initiated Clinical Research Trials: (non- CCG/COG)

1983: UW-Madison. Pilot Study of Intensive Brief Chemotherapy for Stage III and IV Non-Lymphoblastic Lymphoma of Childhood. [Completed, Presented & Published]

1985: UW-Madison. Phase II Trial of Thiotepa and Etoposide with Autologous Bone Marrow Rescue for Children with Recurrent Solid Tumors. [Completed, Presented & Published]

1987: PennU/CHOP. Phase II Trial of Thiotepa and Etoposide for Children with Recurrent Malignant Brain Tumors. [Completed, Presented & Published]

1989: MSKCC-89-173. Pilot Study of Thiotepa, Etoposide and Carboplatin for Children and Adults with Recurrent Malignant Brain Tumors. [Completed, Presented & Published]

1990: MSKCC-90-64. Pilot study of Thiotepa, Etoposide and BCNU prior to Irradiation for Newly-Diagnosed Children and Adults with Glioblastoma Multiforme.[Completed, Presented & Published]

1990: MSKCC-90-70. Pilot Study of Intensive Chemotherapy without Irradiation for Young Children (<3 years of age) Newly Diagnosed with Malignant Brain Tumors. [Completed, Presented & Published]

1990: MSKCC-90-13. Pilot Study of Intensive Chemotherapy for High Risk Malignant B-Cell Lymphoma/B-ALL.Completed, Presented, Not published]

1990: MSKCC-90-15: First International Study of Primary CNS Germ Cell Tumors. [Completed, Presented & Published]

1992: MSKCC-92-16: Pilot Study of Intensive Induction Chemotherapy followed by Consolidative Myeloablative Chemotherapy with Autologous Bone Marrow Rescue. The “Head Start I” Protocol. [Completed, Presented & Published]

1994: MSKCC-94-101. Pilot Study of Thiotepa and Carboplatin with Autologous Stem Cell rescue, following Irradiation, for Children and Adults with Newly-Diagnosed Glioblastoma Multiforme. [Completed, Presented, Not published]

1994: MSKCC-94-125. Second International Study of Primary CNS Germ Cell Tumors. [Completed & Published]

1997: NYU-97-5. Pilot Study of Thiotepa, Etoposide and Carboplatin with Autologous stem cell rescue in adults and children with Recurrent Malignant Brain Tumors [Completed & Published]

1997: NYU-97-12. Pilot Study of Intensive Induction Chemotherapy followed by Consolidative Myeloablative Chemotherapy with Autologous Peripheral Blood Stem Cell Rescue. The “Head Start II” Protocol [Completed & Published]

1997: NYU-97-14. Trial of intensive Chemotherapy and Autotransplantation for Adults with Newly-Diagnosed Pure or Mixed Aggressive Oligodendrogliomas. A Multi-institutional Pilot Study [Completed & Published]

2000: NYU-00-04. Dose Intensive Chemotherapy for Patients >10 years of Age with Newly Diagnosed High Stage Medulloblastoma/PNET and Ependymoma. The “Head Start for Grown-Ups” Protocol. [Completed & Published]

2000: NYU-00-02. Phase II trial of Temozolomide, Carboplatin and Neupogen in Adults and children with High-Grade Gliomas, both Newly-Diagnosed and Recurrent.[Completed, Presented, Not Published]

- 26 -

2000: NYU-00-005. Phase I Trial of continuous Intra-thecal Infusion Topotecan for Adults and Children with Recurrent, Progressive or Refractory Leptomeningeal Neoplasm. [Completed & Published]

2000: NYU-00-006. Dose Escalation of Temozolomide in combination with Thiotepa and Carboplatin with Autologous Stem Cell Rescue, in Adult and Pediatric Patients with Malignant Brain Tumors with Minimal Residual Disease. ((Co-P.I. with Dr. Sharon Gardner)[Completed, Presented, Not Published]

2000: NYU-00-07. Third International Study of Primary CNS Germ Cell Tumors. [Completed & Published]

2002: NYU-02-04. Pilot Study of Intensive Induction Chemotherapy followed by Consolidative Myeloablative Chemotherapy with Autologous Peripheral Blood Stem Cell Rescue. The “Head Start III” Protocol. [Completed, Presented, Manuscripts Published, Submitted or in Preparation]

2004: CHLA: Pilot Study of Intensive Induction Chemotherapy followed by Consolidative Myeloablative Chemotherapy with Autologous Peripheral Blood Stem Cell Rescue. The “Head Start III” Protocol. [Completed, Presented, Manuscripts Published, Submitted or in Preparation]

2004: CHLA: Long Term Follow-up of Outcome and Quality of Life of Survivors of the “Head Start” I and II Protocols. [Ongoing, Manuscripts Published, Submitted or in Preparation]

2004: CHLA: Long Term Follow-up of Outcome and Quality of Life of Survivors of the International CNS Germ Cell Tumor I, II and III Trials. [Ongoing, Manuscripts Published, Submitted or in Preparation]

2011: CHLA: Phase II Trial of GEMPOX followed by Consolidation with Myeloablative Chemotherapy and Autologous Hematopoietic Cell rescue for Children, Adolescents and Young Adults with Recurrent CNS Germ Cell Tumors [Ongoing, Preliminary Presentations]

2014: NCH: Phase II Trial of GEMPOX followed by Consolidation with Myeloablative Chemotherapy and Autologous Hematopoietic Cell rescue for Children, Adolescents and Young Adults with Recurrent CNS Germ Cell Tumors [Ongoing, Preliminary Presentations]

2015: NCH: Study of Intensive Induction Chemotherapy followed by Consolidative Myeloablative Chemotherapy with Autologous Peripheral Blood Cell Rescue. The “Head Start 4” /NEXT Consortium Protocol.

Invited Lectures: National/International and Institutional ( since 1984 ):

1. Invited Lecture, Biogen SA, Geneva, Switzerland. “Interferon-gamma effects upon hemopoiesis in vitro." September 1984.

2. Invited Lecture, Biogen SA, Geneva, Switzerland. “Interferon-gamma effects upon human brain tumors in vitro." September 1984.

3. Invited Presentation, American Cancer Society Science Writers' Symposium. “Advances in the treatment of childhood brain tumors." San Diego, California. April 1985.

- 27 -

4. Invited Presentation, American Society of Clinical Oncology (ASCO) Annual Meeting, National Cooperative Group Update (Educational Symposium). “CCSG trials in the treatment of childhood brain tumors." Houston, Texas. May 1985.

5. Invited Lecture, The Midland Center for Neurosurgery & The Children's Hospital, University of Birmingham, Guest Lecture Series. “Advances in the treatment of childhood brain tumors." Birmingham, England. July 1985.

6. Visiting Professor, University of Manitoba & The Manitoba Cancer Foundation. Neurosciences lecture series: “Advances in the treatment of childhood brain tumors." Winnipeg, Canada. September 1985.

7. Visiting Professor, University of Manitoba & The Manitoba Cancer Foundation. Pediatrics lecture series: “Diagnosis and management of the child with a brain tumor." Winnipeg, Canada. September 1985.

8. Invited Presentation, Sixth International Conference on Brain Tumor Research and Therapy. “Update on progress with the Children's Cancer Study Group (CCSG) trials in the treatment of childhood brain tumors." Ashville, North Carolina. October 1985.

9. Invited Lecture, The Calvo Mackenna Children's Hospital, Santiago, Chile. “Advances in the treatment of childhood brain tumors." July 1986.

10. Invited Lecture, The University of Pennsylvania Veterinary Hospital, Philadelphia, Pennsylvania. “Rational basis for the treatment of childhood brain tumors." August 1986.

11. Chairman, Symposium on Cooperative Group Trials in Pediatric Brain Tumors, 17 th Annual Congress of the International Society of Paediatric Oncology (SIOP), Belgrade, Yugoslavia. September 1986.

12. Lederle Distinguished Lecturer, St. Jude Children's Research Hospital, Memphis, Tennessee. “Advances in the management of childhood brain tumors" and “Pharmacokinetics of Thiotepa in a canine brain model." November 1987.

13. Invited Presentation, Conference on Leukemia Immunology, Division of Allergy-Immunology, Department of Pediatrics, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. November 1987.

14. Invited Presentation, Workshop: Overview of Brain Tumors, Living with Childhood Cancer: A Conference for Parents, American Cancer Society, Philadelphia, Pennsylvania. November 1987.

15. Lederle Distinguished Lecturer, University of Texas Health Science Center, Dallas. “Advances in the management of childhood brain tumors" and "Pharmacokinetics of Thiotepa in a canine brain model." March 1988.

16. Lederle Distinguished Lecturer, Loyola University, Maywood, Illinois. “Advances in the management of childhood brain tumors" and “Pharmacokinetics of Thiotepa in canine brain model." March 1988.

17. Seminar Participant and Co-Chairperson, Preuss Foundation Pediatric Glioma Seminar, San Francisco, California. November 1988.

18. Invited Presentation, William Guy Forbeck Foundation Annual Forum. “Improving drug delivery to brain tumors." Hilton Head, South Carolina. November 1988.

19. Invited Lecture (Glaxo Professor), International Symposium on Pediatric Neuro-oncology. “Marrow grafting and high-dose chemotherapy." Seattle, Washington. June 1989.

20. Invited Lecture, 2nd International Symposium on Pediatric Neuro-oncology (ISPNO). “Management of high-grade astrocytoma of childhood." Seattle, Washington. June 1989.

21. Clinical Sciences Lectureship Program, Fred Hutchinson Cancer Research Center, Seattle, Washington. “New approaches to the treatment of brain tumors: marrow transplantation and beyond." June 1989.

- 28 -

22. Pediatric Neurology Grand Rounds, Columbia University, New York, New York. “New approaches to the treatment of brain tumors." October 1989.

23. Invited Lecture, Roentgen Society of New York, Annual Meeting. “Advances in chemotherapy of childhood brain tumors." May 1990.

24. Grand Rounds, Department of Pediatrics, North Shore University Medical Center, Manhasset, New York. “Progress in the treatment of childhood brain tumors." January 1990.

25. Post-graduate Course on Pediatric Neuro-Oncology, Institut Besta National, Milan, Italy. Invited Introductory and Concluding Lectures. “The multidisciplinary approach to the management of childhood brain tumors." March 1990.

26. Invited Lecture, 3rd International Symposium on Pediatric Neuro-oncology (ISPNO), Philadelphia, Pennsylvania. “High-dose chemotherapy and autologous marrow rescue in brain tumors." May 1990.

27. Invited Presentation, Fifth International Symposium on Autologous Bone Marrow Transplantation, Omaha, Nebraska. “High-dose chemotherapy with autologous bone marrow rescue in the treatment of malignant brain tumors." August 1990.

28. Pediatric Grand Rounds, Children's Hospital of Orange County, Orange, California. “Current progress in the treatment of childhood brain tumors." August 1990.

29. Pediatrics Grand Rounds, Duke University Medical Center, Durham, North Carolina. “High-dose chemotherapy with autologous marrow rescue in pediatric brain tumors." September 1990.

30. Invited Lecture, American Society of Therapeutic Radiologists (ASTRO) Annual Meeting, Miami, Florida. “Progress in the treatment of malignant astrocytomas of childhood." October 1990.

31. Bone Marrow Transplant Program Seminar, University of Connecticut, Farmington, Connecticut. “High-dose chemotherapy with autologous marrow rescue in childhood brain tumors." October 1990.

32. Department of Pediatrics Grand Rounds, University of Connecticut, Farmington, Connecticut. “Progress in the treatment of childhood brain tumors." October 1990.

33. Invited Lecture, Department of Pediatrics, M.D. Anderson Cancer Center, Houston, Texas. “High-dose chemotherapy with autologous marrow rescue in treatment of brain tumors." November 1990.

34. Invited Presentation, M.D. Anderson 34th Annual Cancer Conference: Advances in Brain Tumor Therapy, Houston, Texas. “Phase III trials of high-grade astrocytomas of childhood” in Pediatric Brain Tumor Workshop. November 1990.

35. Invited Lecture, Dana Farber Cancer Center, Pediatric Grand Rounds, Boston, Massachusetts. “High-dose chemotherapy with autologous marrow rescue in pediatric brain tumors." January 1991.

36. Invited Lecture, Robert Wood Johnson Medical Center; Regional Pediatric Oncologists Quarterly Lecture Series, New Brunswick, New Jersey. “High-dose chemotherapy with autologous marrow rescue in childhood brain tumors." September 1991.

37. Fourth Annual Meeting of the American Society of Pediatric Hematology/ Oncology (ASPHO), Chicago, Illinois. Chairman of Symposium: “Progress in Pediatric Brain Tumors” and Lecture, “Current results of the CCSG brain tumors trials." September 1991.

38. Invited Presentation, Ninth International Conference for Brain Tumor Research and Therapy, Asilomar, California. “High-dose chemotherapy and autologous bone marrow rescue in the treatment of brain tumors of childhood and adolescence." October 1991.

- 29 -

39. Invited Lecture, 4th International Symposium on Pediatric Neuro-Oncology (ISPNO), Tokyo, Japan. “High-dose chemotherapy and autologous marrow rescue in childhood brain tumors." November 1991.

40. Invited Lecture, 4th International Symposium on Pediatric Neuro-Oncology (ISPNO), Tokyo, Japan. “Results of CCSG Trials in Childhood Malignant Gliomas.” November 1991.

41. Invited Lecture, 4th International Symposium on Pediatric Neuro-Oncology (ISPNO), Tokyo, Japan. “Treatment of Astrocytoma (Cerebral)." November 1991.

42. Invited Lecture, Annual Meeting of the Clinical Oncology Society of Australia (COSA), Sydney. “Progress in the treatment of malignant gliomas." December 1991.

43. Invited Lecture, Annual Meeting of the Clinical Oncology Society of Australia (COSA), Sydney. “Progress in the treatment of medulloblastoma.” December 1991.

44. Invited Lecture, 5th International Symposium on Pediatric Neuro-Oncology (ISPNO), Sao Paolo, Brazil. “Bone marrow transplantation in the treatment of central nervous system tumors." March 1992.

45. Invited Lecture, 5th International Symposium on Pediatric Neuro-Oncology (ISPNO), Sao Paolo, Brazil. “Results of CCG studies in medulloblastoma." March 1992.

46. Invited Lecture, 5th International Symposium on Pediatric Neuro-Oncology (ISPNO), Sao Paolo, Brazil. “Chemotherapy in the treatment of childhood brain tumors - state of the art." March 1992.

47. Invited Lecture, 5th International Symposium on Pediatric Neuro-Oncology (ISPNO), Sao Paolo, Brazil. “Treatment of children less than 3 years of age at diagnosis with malignant brain tumors." March 1992.

48. Organizing Chairman and Presenter, Educational Symposium. “Progress in childhood brain tumors." Annual Meeting of the American Society of Clinical Oncology (ASCO), San Diego, CA. May 1992.

49. Invited Lecture, International Cancer Conference, Columbus, Ohio. “Controversies and progress in the treatment of brain tumors." September 1992.

50. Pediatric Oncology Group, Biannual Meeting. “High-dose chemotherapy strategies for the treatment of malignant brain tumors." St. Louis, MO. October 1992.

51. Visiting Professor, Organizado por Unidad de Pediatrica del Instituto Dr. Estevez, Neuro-oncology Workshop. Invited Lecture: “State of the art in CNS tumors" (Presentation to the Research Institute of Neurological Disease in Children). Buenos Aires, Argentina. April 1993.

52. Visiting Professor, Organizado por Unidad de Pediátrica del Instituto Dr. Estévez, Neuro-oncology Workshop. Invited Lecture. “Germ cell tumors in the central nervous system." Buenos Aires, Argentina. April 1993.

53. Visiting Professor, Organizado por Unidad de Pediátrica del Instituto Dr. Estévez, Neuro-oncology Workshop. Invited Lecture. “High-dose chemotherapy and bone marrow rescue in the treatment of tumors of the central nervous system." Buenos Aires, Argentina. April 1993.

54. Visiting Professor, Organizado por Unidad de Pediátrica del Instituto Dr. Estévez, Neuro-oncology Workshop. Invited Lecture. “Current status of treatment for medulloblastoma." Buenos Aires, Argentina. April 1993.

55. Visiting Professor, Organizado por Unidad de Pediátrica del Instituto Dr. Estévez, Neuro-oncology Workshop. Invited Lecture. “High-grade Astrocytoma.” Buenos Aires, Argentina. April 1993.

56. Visiting Professor, Organizado por Unidad de Pediátrica del Instituto Dr. Estévez, Neuro-oncology Workshop. Invited Lecture. “Myeloablative chemotherapy and bone marrow rescue in central nervous system malignant tumors." Buenos Aires, Argentina. April 1993.

- 30 -

57. Invited Lecture, Third Annual Neuro-Oncology Symposium (in memoriam of Professor Julian Bloom), The Royal Marsden Hospital, London. “Advances in the treatment of childhood medulloblastoma." April 1993.

58. Invited Lecture, Third Annual Neuro-Oncology Symposium (in memoriam of Professor Julian Bloom), The Royal Marsden Hospital, London. “Chemotherapy strategies in the treatment of primary CNS germ cell tumors." April 1993.

59. Invited Lecture, Pediatric Neuro-oncology Program, University of Texas Health Sciences Center, Dallas. “High-dose chemotherapy with marrow rescue in childhood brain tumors.” May 1993.

60.Grand Rounds, Department of Neurosurgery, New York Medical College, Westchester County Medical Center, Valhalla, New York. “Progress in the chemotherapy of childhood brain tumors." May 1993.

61. Invited Lecture, 5th International Symposium on Pediatric Neuro-Oncology (ISPNO), Marseilles France. “Strategies incorporating high-dose chemotherapy with marrow rescue in childhood brain tumors." June 1993.

62. Invited Presentation, Workshop on “Primary CNS germ cell tumors." Padova, Italy. August 1993

63. Invited Presentation, 10th International Conference on Brain Tumor Research and Therapy, Voss, Norway. “High-dose chemotherapy with autologous marrow rescue improves survival of patients with recurrent malignant glioma compared with conventional or no chemotherapy." September 1993.

64. Invited Lecture, Birmingham Children’s Hospital, Birmingham, England. “Innovative chemotherapeutic strategies in the management of brain tumors of childhood." November 1993.

65. Invited Lecture, D.C. Children's Hospital, Washington, D.C. “The role of myeloablative chemotherapy and stem cell rescue in the management of medulloblastoma/PNET." February 1994.

66. Invited Lecture, Children's Hospital of Philadelphia, Philadelphia, PA. “The role of bone marrow transplantation in pediatric brain tumor therapy." April 1994.

67. Invited Lecture, 6th International Symposium on Pediatric Neuro-oncology (ISPNO), Houston, TX. “High-dose chemotherapy and autologous bone marrow rescue for malignant brain tumors." May 1994.

68. Keynote Address, 6th Canadian Neuro-oncology Meeting, Lake Louise, Alberta. “Strategies incorporating high-dose chemotherapy with autologous marrow rescue in the management of malignant brain tumors." May 1994.

69. Invited Lecture, International Pediatric Neuro-Oncology Symposium, Santiago, Chile. “Chemotherapy of CNS tumors." May 1994.

70. Invited Lecture, International Pediatric Neuro-Oncology Symposium, Santiago, Chile. “Management of primary CNS germ cell tumors." May 1994.

71. Invited Lecture, International Pediatric Neuro-Oncology Symposium, Santiago, Chile. “Autologous bone marrow transplant in CNS tumors." May 1994.

72. Invited Lecture, International Symposium on Neuro-Oncology, Buenos Aires, Argentina. “Advances in therapy of CNS germ cell tumors." June 1994.

73. Invited Lecture, International Symposium on Neuro-Oncology, Buenos Aires, Argentina. “Management of medulloblastoma." June 1994.

74. Invited Lecture, International Symposium on Neuro-Oncology, Buenos Aires, Argentina. “Bone marrow transplants in pediatric neuro-oncology." June 1994.

75. Invited Lecture, St. Bartholomew's Hospital, London, U.K. “Controversies and progress in the management of medulloblastoma." September 1994.

- 31 -

76. Invited Presentation, Glioblastoma Workshop, Fred Hutchinson Cancer Center, Seattle, WA. December 1994.

77. Invited Presentation, University of Pennsylvania Conference: “The Evolving Role of Radiation in Pediatric Oncology." “The expanding role of chemotherapy for childhood brain tumors." January 1995.

78. Invited Presentation, Plenary Session, North American Autologous Bone Marrow Transplantation Registry Symposium (IBMTR), “Autologous stem cell strategies in brain tumors." Keystone, CO. January 1995.

79. Pediatric Branch, National Cancer Institute, Grand Rounds. “The evolving role of chemotherapy for childhood brain tumors." February 1995.

80. Pediatric Grand Rounds, Maimonides Medical Center, Brooklyn, New York. “Evolving role of chemotherapy in the management of childhood brain tumors." February 1995.

81. Invited Lecture, Department of Pediatrics, University of Malaysia Hospital, Kuala Lumpur, Malaysia. “The evolving role of chemotherapy in the management of childhood brain tumors." February 1995.

82. Invited Lecture, Singapore General Hospital "Neuroscience Update" Symposium, Singapore. “Chemotherapy strategies for primary intracranial germ cell tumors." February 1995.

83. Invited Lecture, Singapore General Hospital "Neuroscience Update" Symposium, Singapore. “Myeloablative Chemotherapy Strategies for primary malignant brain tumors." February 1995.

84. Invited Lecture, Department of Pediatrics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong. “Treatment of medulloblastoma/PNET - truth and consequences.” February 1995.

85. Invited Lecture, Department of Pediatrics, Chinese University of Hong Kong, Hong Kong. “Management of primary intracranial germ cell tumors." February 1995.

86. Pediatric Grand Rounds, University of Wisconsin-Center for Health Sciences, Madison, Wisconsin. “Pediatric brain tumors." May 1995.

87. Invited Lecture, Wisconsin Clinical Cancer Center, Madison, Wisconsin. “Role of chemotherapy in the treatment of primary brain tumors." May 1995.

88. Invited Lecture, Department of Radiation Oncology, Wisconsin Clinical Cancer Center, Madison, Wisconsin. “Management of high-grade astrocytomas." May 1995.

89. Invited Lecture, 11th International Conference on Brain Tumor Research and Therapy, Napa, California. “High-dose chemotherapy with stem cell rescue strategies in malignant gliomas." November 1995.

90. Invited Presentation, Workshop on Pediatric Malignancies, Sixth Keystone, Colorado, Biennial Keystone Sandoz Symposium on Blood and Marrow Transplantation. “High-dose chemotherapy with stem cell rescue in malignant brain tumors." January 1996.

91. Invited Lecture, Workshop on Childhood Brain Tumors, Russian Research Institute of Paediatric Haematology, Moscow, Russia. “Chemotherapy of posterior fossa tumors." February, 1996.

92. Invited Lecture, Workshop on Childhood Brain Tumors, Russian Research Institute of Paediatric Haematology, Moscow, Russia. “Chemotherapy of supratentorial tumors." February 1996.

93. Invited Lecture, Eighth Annual Bone Marrow and Stem Cell Transplantation Symposium, Albert Einstein College of Medicine, New York. “High-dose chemotherapy with stem cell transplantation for CNS tumors." March 1996.

- 32 -

94. Invited Lecture, Second Annual Northern New Jersey Cancer Center Research Symposium. “High-dose chemotherapy with stem cell rescue for children and young adults with primary brain tumors." May 1996.

95. Invited Lecture, 7th International Symposium on Pediatric Neuro-oncology (ISPNO), Washington D.C. “The Role of high-dose chemotherapy with stem cell rescue in medulloblastoma/PNET." May 1996.

96. Invited Lecture, 7th International Symposium on Pediatric Neuro-oncology (ISPNO), Washington D.C. “The role of high-dose chemotherapy with stem cell rescue in high-grade gliomas." May 1996.

97. Invited Lecture, Children’s Hospital of Orange County, California. “Strategies of high-dose chemotherapy with stem cell rescue in malignant brain tumors.” June 1996.

98. Invited Lecture, Hospital de Pediatria Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina. “New developments in the management of childhood brain tumors." September 1996.

99. Invited Lecture, Instituto FLENI (Federal Institute of Neurology), Buenos Aires, Argentina. Conference: “Autologous Bone Marrow Transplantation for Nervous System Tumors": “The State of Neuro-oncology". September 1996.

100. Invited Lecture, Instituto FLENI (Federal Institute of Neurology), Buenos Aires, Argentina. Conference: “Autologous Bone Marrow Transplantation for Nervous System Tumors". “High-dose chemotherapy strategies for patients with malignant gliomas". September 1996.

101. Invited Lecture, Instituto FLENI (Federal Institute of Neurology), Buenos Aires, Argentina. Conference: “Autologous Bone Marrow Transplantation for Nervous System Tumors". “High-dose chemotherapy strategies for patients with recurrent medulloblastoma/PNET". September 1996.

102. Invited Lecture, Instituto FLENI (Federal Institute of Neurology), Buenos Aires, Argentina. Conference: “Autologous Bone Marrow Transplantation for Nervous System Tumors": “High-dose chemotherapy strategies for young children with newly-diagnosed malignant brain tumors". September 1996.

103. Invited Lecture, 9th Annual Meeting of the American Society of Pediatric Hematology/Oncology (ASPHO), Chicago. “High-dose chemotherapy with stem cell rescue for CNS tumors in children". October 1996.

104. Invited Lecture. Hospital Infantil Pequeno Principe, Curitiba, Brasil. “Progress in the treatment of childhood brain tumors". November 1996.

105. Invited Lecture, Second International Neuro-oncology Symposium, Sao Paolo, Brasil. “New approaches to the treatment of high-grade gliomas”. November 1996.

106. Invited Lecture, Second International Neuro-oncology Symposium, Sao Paolo, Brasil. “Chemotherapy for Medulloblastoma”. November 1996.

107. Invited Lecture, Paraguayan Society of Pediatrics, La Catedra de Pediatria, Asuncion, Paraguay. “Management of malignant childhood brain tumors”. November 1996.

108. Invited Speaker, Harvard Medical School Post-graduate Course: “Tumors of the Central Nervous System”, Boston. “High-dose chemotherapy for brain tumors.” November 1996.

109. Invited Speaker, Symposium: “Neuro-oncology VI: Recent Advances in Diagnosis and Treatment.” Memorial Sloan-Kettering Cancer Center, New York. “High-dose chemotherapy with stem cell rescue for brain tumors”. December 1996.

110. Invited Lecture, Department of Medical Oncology, New York University Medical Center. “Progress in the treatment of malignant brain tumors.” January 1997.

- 33 -

111. Neuro-surgical Grand Rounds, New York Medical College, Valhalla, New York. “Progress in the treatment of malignant brain tumors.” January 1997.

112. Invited Lecture, Instituto FLENI (Federal Institute of Neurology), Buenos Aires, Argentina. “High-dose chemotherapy with stem cell rescue strategies for adult malignant brain tumors.” October 1997.

113. Invited Lecture, Instituto FLENI (Federal Institute of Neurology), Buenos Aires, Argentina. “High-dose chemotherapy with stem cell rescue strategies for infants and young children with malignant brain tumors.” October 1997.

114. Invited Lecture, International Bone Marrow Transplantation Registry Annual Meeting, Keystone, Colorado. “High-dose chemotherapy with stem cell rescue in malignant brain tumors: pros and cons.” January 1998.

115. Invited Lecture, Second International Neuro-oncology Meeting, Buenos Aires, Argentina. “Chemotherapy for low-grade gliomas of childhood.” April 1998.

116. Invited Lecture, Second International Neuro-oncology Meeting, Buenos Aires, Argentina. “High-dose chemotherapy with autologous stem cell rescue for malignant brain tumors.” April 1998.

117. Invited Lecture, 4th Pediatric Bone Marrow Transplantation Conference, Palm Beach, Florida. “Role of high-dose chemotherapy with autologous stem cell rescue in the management of malignant brain tumors of childhood.” June 1998.

118. Invited Lecture, 18th Annual Meeting of the British Neuro-oncology Group, Wye College, University of London, Kent, UK. “Chemotherapy for childhood brain tumors.” July 1998.

119. Invited Seminar, A Systems Approach to the Management of Glial Neoplasms, New York University Medical Center. “Treatment strategies for Childhood Malignant Gliomas.” November 1998.

120. Invited Seminar, A Systems Approach to the Management of Glial Neoplasms, New York University Medical Center. “High dose Chemotherapy and Stem Cell Support for Malignant Gliomas.” November 1998.

121. Invited Lecture, 5th Uruguayan Congress of Oncology, Montevideo, Uruguay. “Chemotherapy in the Management of Young Children with Brain Tumors.” November 1998.

122. Invited Lecture, 5th Uruguayan Congress of Oncology, Montevideo, Uruguay. “High dose Chemotherapy for Central Nervous System Tumors.” November 1998.

123. Invited Lecture, 5th Uruguayan Congress of Oncology, Montevideo, Uruguay. “New Agents in Neuro-oncology.” November 1998.

124. Invited Lecture, 5th Uruguayan Congress of Oncology, Montevideo, Uruguay. “Low grade Gliomas of Adults and Children.” November 1998.

125. Invited Lecture, Department of Pediatrics Grand Rounds, New York University School of Medicine. “Childhood Cancer: Changing Challenges in a Changing World.” January 1999.

126. Invited Lecture, University of Minnesota Cancer Center, Minneapolis. “Childhood Brain Tumors: Are we making Progress?” February 1999.

127. Invited Lecture, Department of Neurosurgery Grand Rounds, New York University School of Medicine. “Chemotherapy for Childhood Brain Tumors.” February 1999.

128. Invited Lecture, Cleveland Clinic Neuro-oncology Symposium, Naples, Florida. “Chemotherapy for Malignant Glial Tumors of Childhood.” February 1999.

- 34 -

129. Invited Lecture, Cleveland Clinic Neuro-oncology Symposium, Naples, Florida. “High-dose Chemotherapy with Stem Cell Rescue Strategies for Malignant Gliomas.” February 1999.

130. Invited Lecture, Pediatric Grand Rounds, Brookdale Hospital-City University of New York, Brooklyn. “Progress in the Treatment of Childhood Brain Tumors.” April 1999.

131. Invited Lecture, Symposium: “Neuro-genetics for the Practitioner”, New York University. “Molecular Genetics of Childhood Brain Tumors.” October 1999.

132. Invited Lecture, Symposium: “Midline Gliomas of Childhood”, Institute of Neurology and Neurosurgery, Beth Israel Medical Center New York. “Chemotherapy of high-grade childhood gliomas.” November 1999.

133. Keynote Lecture: Symposium on Pediatric Neuro-oncology, University of Minnesota, Minneapolis. “New approaches to the management of childhood brain tumors.” November 1999.

134. Invited Lecture, World Congress of Pediatric Neurosurgery: (State of the art and perspectives for the third millennium), Martinique. “Impact of extent of resection on the multi-modality treatment of childhood high grade gliomas.” December 1999.

135. Invited Lecture, World Congress of Pediatric Neurosurgery: (State of the art and perspectives for the third millennium), Martinique. “Role of surgery in the management of primary CNS germ cell tumors”. December 1999.

136. Visiting Scholar, University of Florida at Gainesville, FL. “Progress in the Management of Childhood Cancer: The Road Ahead.” March 2000.

137. Visiting Scholar, University of Florida at Gainesville, FL. “The Role of High Dose Chemotherapy with Stem Cell Rescue in the Management of Childhood Brain Tumors.” March 2000.

138. Invited Lecture, Instituto de Prevision Social Central Hospital, Asuncion, Paraguay. “The Role of Surgical Resection in the Management of Primary Brain Tumors.” May 2000.

139. Invited Lecture, Hospital de las Clinicas, Catedra de Pediatria, Asuncion, Paraguay. “Role of Chemotherapy in the Management of Childhood Malignant Brain Tumors.” May 2000.

140. Invited Lecture, Sociedad Paraguaya de Pedriatria, Asuncion, Paraguay. “Treatment of Childhood Cancer in the New Millennium. A Global Perspective.” May 2000.

141. Lecture, Annual Pediatric Review Symposium of New York University Medical Center. “Langerhans Cell Histiocytosis.” May 2000.

142. Invited Lecture, 9th International Symposium on Pediatric Neuro-oncology (ISPNO), San Francisco, California. “Management of CNS germ cell tumors of childhood.” June 2000.

143. Invited Lecture. 9thInternational Symposium on Pediatric Neuro-oncology (ISPNO), San Francisco, California. “Role of high-dose chemotherapy with stem cell rescue in the management of childhood brain tumors.” June 2000.

144. Year 2000 Adam Balinsky Memorial Lecture, the Hospital for Sick Children, Toronto, Canada. “Progress and Pitfalls in the Management of High-Grade Gliomas of Childhood”. October 2000.

145. Invited Speaker, Workshop on Atypical Teratoid/Rhabdoid Tumors in Childhood, National Cancer Institute, Bethesda, MD. “Role of Myeloablative chemotherapy with autologous stem cell rescue in ATT/R Tumors of the CNS”. January 2001

146. Invited Lecture, Pediatric Hematology/Oncology Post-Graduate Course, University of Medicine and Dentistry of New Jersey, Breckenbridge, Colorado. “Progress in the Management of Childhood Non-Hodgkin’s lymphomas”, February 2001.

- 35 -

147. Invited Lecture, Pediatric Hematology/Oncology Post-Graduate Course, University of Medicine and Dentistry of New Jersey, Breckenbridge, Colorado. “Progress in the Management of Childhood Brain Tumors”. February 2001.

148. Honorary Speaker and Coordinator, 1st International Conference on Asian Therapies for Cancer. Brain Tumor Grand Rounds, New York City, March 2001.

149. Invited Speaker, Pediatric Brain Tumor Consortium (PBTC) Biennial Meeting, Chicago. “A Phase I Study of Intrathecal Continuous Infusion Topotecan for children with recurrent leptomeningeal disease. March, 2001.

150. Invited Lecture, Instituto de Prevision Social Central Hospital, Asuncion, Paraguay. “The Management of Adult Malignant Gliomas”.July 2001.

151. Invited Lecture, Hospital de las Clinicas, Catedra de Pediatria, Asuncion, Paraguay. “Prognostic Markers in Childhood Cancer: July 2001.

152. Invited Lecture, Sociedad Paraguaya de Pedriatria, Asuncion, Paraguay. “Prognostic Markers in Childhood Cancer”. July 2001.

153. Invited Lecture, Third International Neuro-oncology Meeting, Buenos Aires, Argentina. “Chemotherapy for low-grade gliomas of childhood.” September 2001.

154. Invited Lecture, Third International Neuro-oncology Meeting, Buenos Aires, Argentina. “Chemotherapy for Adult Low-Grade Gliomas”. September 2001.

155. Invited Presentation, Workshop on Primary CNS Germ Cell Tumors, American Society of Therapeutic Radiology Annual (ASTRO) Meeting, San Francisco. “Chemotherapy for CNS Germinomas”, November 2001.

156. Neurosurgical Grand Rounds, New York University Medical Center. "Brain Tumor as Chronic Disease: The Management of Low Grade Gliomas of Adults and Children", March, 2002.

157. Invited Lecture, Annual Meeting of the Nordic Society of Pediatric Hematology/Oncology, Helsinki, Finland. "Myeloablative Chemotherapy Strategies in the Management of Childhood Brain Tumors", May 2002.

158. Keynote Lecture, 10th International Symposium of Pediatric Neuro-oncology (ISPNO), London, England. "High Dose Chemotherapy Strategies in the Management of Young Children with Malignant Brain Tumors", June 2002.

159. Invited Lecture, Annual Meeting of the Brazilian Society of Pediatric Oncology (SOBOPE), Sao Paulo, Brazil. “Management of Childhood Medulloblastoma”, August 2002.

160. Invited Lecture, Annual Meeting of the Brazilian Society of Pediatric Oncology (SOBOPE), Sao Paulo, Brazil. “Management of Malignant Brain Tumors of Young Children”, August 2002.

161. Invited Lecture, Annual Meeting of the Brazilian Society of Pediatric Oncology (SOBOPE), Sao Paulo, Brazil. “Management of Low Grade Gliomas of Childhood”, August 2002.

162. Invited Lecture, 10th International Symposium on Pediatric Neuro-oncology (ISPNO), London, England. “Role of Myeloablative Chemotherapy and Autologous Hematopoietic Stem Cell Rescue in the Management of Young Children with Malignant Brain Tumors”, June 2002.

163. Invited Lecture, 34th Annual Congress of the International Society of Paediatric Oncology (SIOP), Oporto, Portugal. “Role of Myeloablative Chemotherapy with Autologous Hematopoietic Stem Cell Rescue in the Management of Malignant Gliomas”, September 2002.

- 36 -

164. Invited Seminar, Gornoslaskie Centrum Zdrowia I Matki (Mother and Children’s Hospital), Neurosurgery Department, Katowice, Poland. “Brain Cancer as Chronic Disease: The Management of Childhood Low Grade Gliomas”, October 2002.

165. Invited Seminar, Lublin University Hospital, Departments of Neurosurgery and Pediatric Oncology, Lublin, Poland. “Brain Cancer as Chronic Disease: The Management of Childhood Low Grade Gliomas”, October 2002.

166. Invited Seminar, Mother’s and Children’s Memorial Hospital, Department of Pediatric Oncology, Warsaw, Poland. “Brain Cancer as Chronic Disease: The Management of Low Grade Gliomas of Childhood”, October 2002.

167. Invited Lecture, Hematology-Oncology Grand Rounds, Children’s Hospital Los Angeles. “Management of Young Children with Malignant Brain Tumors: 10 Years of ‘Head Start’ Strategies”, December 2002.

168. Invited Lecture, Department of Pediatrics Grand Rounds, New York University Medical Center: “Management of Young Children with Malignant Brain Tumors: 10 Years of ‘Head Start’ Strategies”, January 2003.

169. The John Revere Society and 1841 Society of NYU Medical Center Lectureship: “Dream Becomes Reality: The Truly Cured Child with Brain Cancer”, NYU Medical Center, New York, January 2003.

170. Invited Seminar, Dept. of Neurological Surgery, University of Southern California School of Medicine. “Brain Cancer as Chronic Disease: The Management of Adults with Low Grade Glial Tumors”, January 2003.

171. Invited Seminar, University of Kentucky, Lexington, Department of Pediatrics. “Brain Cancer as chronic disease: The management of children with low grade glial tumors”, May 2003.

172. Pediatric Grand Rounds, University of Lexington, Kentucky. “The Management of Young Children with Malignant Brain Tumors: A decade of Head Start Chemotherapy only strategies”. May 2003.

173. Pediatric Grand Rounds, Staten Island University Medical Center, New York: “The Management of Young Children with Malignant Brain Tumors”, June 2003.

174. Invited Lecture, First Brazilian Congress of Neuro-oncology, Sao Paulo, Brazil. “The Role of Myeloablative Chemotherapy with Stem Cell rescue in the Management of recurrent Medulloblastoma/PNET”. August, 2003.

175. Invited Lecture, First Brazilian Congress of Neuro-oncology, Sao Paulo, Brazil. “The Management of Young Children with Malignant Brain Tumors”. August 2003.

176. Invited Lecture, First Brazilian Congress of Neuro-oncology, Sao Paulo, Brazil. “The Management of Ependymomas”. August 2003.

177. Invited Lecture, First Brazilian Congress of Neuro-oncology, Sao Paulo, Brazil. “The Management of Low Grade Gliomas of Childhood”. August 2003.

178. Invited Lecture, First Brazilian Congress of Neuro-oncology, Sao Paulo, Brazil.” The Role of Myeloablative Chemotherapy with Stem Cell Rescue in the Management of Malignant Gliomas”. August 2003.

179. Invited Lecture, 1st International Symposium on CNS Germ Cell Tumors, Kyoto, Japan. “Brain Cancer as Chronic Disease: The Management of Low Grade Glial Tumors in Children and Adults”. September 2003.

180. Pediatric Oncology Grand Rounds, Children’s Hospital Los Angeles. “Development of Brain Tumor Treatment Protocols of the National Children’s Cooperative Oncology Groups (CCG, POG and COG)”, November, 2003.

181. Pediatric Oncology Grand Rounds, Memorial Sloan-Kettering Cancer Center, New York. “Management of Young Children with Malignant Brain Tumors”, March 2004.

182. Invited Lecture, Southern California Pediatric Oncology Nurses (SCAPON) Society. “The Young Child with a Malignant Brain Tumor”, May 2004.

- 37 -

183. Invited Lecture, Pediatric Grand Rounds, Children’s Hospital Los Angeles. “Progress in the Management of Young Children with Malignant Brain Tumors”, August 2004.

184. Invited Lecture, Post-Graduate Course on Pediatric Oncology, Annual Congress of the International Society of Paediatric Oncology (SIOP), “Progress in the Treatment of Childhood Brain Tumors”. Oslo, Norway, September 2004.

185. Pediatric Grand Rounds, Loma Linda University, CA. “Progress in the Management of Young Children with Malignant Brain Tumors”, October, 2004.

186. Invited Speaker, Maxine Dunitz Neurosurgical Center, Cedars-Sinai Medical Center, Los Angeles, Annual Patient/Families Symposium on Brain Tumors. “From Dream to Reality: Progress in the treatment of Malignant Brain Tumors in Young Children”. October, 2004.

187. Invited Speaker, Brain Tumor Awareness Day, New York University Medical Center, New York. “From Dream to Reality: Progress in the treatment of Malignant Brain Tumors in Young Children”. November 2004.

188. Invited Speaker, Ninth Annual Meeting of the Society of Neuro-oncology, Toronto, Canada. Education Day: Pediatric Brain Tumors: “Current Management of Patients with Primary CNS Germ Cell Tumors”. November 2004.

189. Invited Speaker, Oncology Grand Rounds, Children’s Hospital Los Angeles. “Annual Update on Children’s Oncology Group Brain Tumor Trials” December 2004.

190. Visiting Lecturer, University of Sao Paolo Children’s Cancer Hospital, Sao Paolo, Brazil. “Management of CNS Germ Cell Tumors”, January 2005.

191. Visiting Lecturer, University of Sao Paolo Children’s Cancer Hospital, Sao Paolo, Brazil. “Management of Young Children with Malignant Brain Tumors”. January 2005.

192. Invited Speaker, Annual meeting of the ASBMT/IBMTR, Keystone, Colorado. “Role of Myeloablative Chemotherapy with Autologous Hematopoietic Cell Rescue in Childhood Malignant Brain Tumors”. February 2005.

193. Invited Speaker, Hematology Grand Rounds, University of Southern California Hospital and L.A. County Medical Center. “Role of Myeloablative Chemotherapy with Stem Cell Rescue in Adult Malignant Brain Tumors”. March 2005.

194. Alberta Heritage Foundation for Medical Research Lecturer, University of Calgary, Alberta, Canada. “The Role of Myeloablative Chemotherapy with Hematopoietic Cell Rescue in Adult Brain Tumors”, March 2005.

195. Visiting Professor, Alberta Children’s Hospital, Calgary, Alberta, Canada. “Management of Young Children with Malignant Brain Tumors: 12 Years of the “Head Start” Program. March 2005.

196. Speaker, Neurosciences Seminar, Children’s Hospital Los Angeles. “The Role of Myeloablative Chemotherapy with Hematopoietic Cell Rescue in Childhood Brain Tumors”. March 2005.

197. Invited lecturer, Pediatric Grand Rounds, Sunrise Children’s Medical Center, Las Vegas, Nevada. “Management of Young Children with Malignant Brain Tumors”. June 2005.

198. Visiting Professor, Dept. of Neurological Surgery, University of California-San Francisco. “The Role of Myeloablative Chemotherapy with Hematopoietic Cell Rescue in Adult Brain Tumors”, San Francisco, July 2005.

199. Visiting Professor, Hospital de Clinicas, Institute of Pediatric Oncology, University of Rio Grande do Sul, Porto Alegre, Brasil. “Tumors of the Central nervous System: Diagnosis and Treatment”. Porto Alegre, Brazil, August 2005.

- 38 -

200. Visiting Professor, Hospital de Clinicas, Institute of Pediatric Oncology, University of Rio Grande do Sul, Porto Alegre, Brasil. “Brain Cancer as Chronic Disease: the Management of Childhood Low grade Gliomas”. Porto Alegre, Brazil, August 2005.

201. Invited speaker, 6th Symposium & Workshop of the Society of Neurology & Neurosurgery of Rio Grande do Sul. “Integrated Treatment of CNS Germ Cell Tumors”. Porto Alegre, Brazil, August 2005.

202. Invited speaker, 6th Symposium & Workshop of the Society of Neurology & Neurosurgery of Rio Grande do Sul. “High dose chemotherapy with autologous stem cell rescue in the treatment of patients with recurrent malignant brain tumors. Porto Alegre, Brazil, August 2005.

203. Invited speaker, CRIANCA 2005, 2nd International Congress of Pediatric Specialties. “Pitfalls and Benefits of clinical Trials in Management of Childhood Medulloblastoma”. Curitiba, Brazil, August 2005.

204. Invited speaker, CRIANCA 2005, 2nd International Congress of Pediatric Specialties. “Role of Myeloablative Chemotherapy with Autologous Hematopoietic Cell Rescue in Childhood Brain Tumors. Curitiba, Brazil, August 2005.

205. Invited speaker, CRIANCA 2005, 2nd International Congress of Pediatric Specialties. “The Management of Young Children with Malignant Brain Tumors”. Curitiba, Brazil, August 2005.

206. Invited lecturer. Pediatric Grand Rounds, Miller Children’s Hospital & Long Beach Memorial Hospital. “The Management of Young Children with Malignant Brain Tumors” Long Beach, California, September 2005.

207. Presidential Address: the Second International Symposium on CNS Germ Cell Tumors.Universal City, California, November 2005.

208. Invited Speaker, 10th Annual Meeting, Southern California Association of Pediatric Oncology Nurses. “The Role of Myeloablative Chemotherapy with Hematopoietic Cell Rescue in Childhood Brain Tumors”, Rancho Mirage, California, May 2006.

209. Keynote Lecture, 12th International Symposium on Pediatric Neuro-oncology. “Is there a Role for Myeloablative Chemotherapy in the Management of Children with Malignant Gliomas?, Nara, Japan, June 2006.

210. Invited Lecture, Educational Symposium, 12th International Symposium on Pediatric Neuro-oncology. “High Dose Chemotherapy for Pediatric Brain Tumors”, Nara, Japan, June 2006.

211. Invited presentation, Schering-Plough North American Temodar Investigators’ Meeting. “The Head Start protocols for newly diagnosed malignant brain tumors of early childhood”, Chicago, July 2006.

212. Invited Lecture, 15th Anniversary Symposium on Establishment of Pediatric Bone Marrow Transplantation Program, Cancer Research Center of the Russian Academy of Sciences. “The Management of Young Children with Malignant Brain Tumors; Role of Myeloablative Chemotherapy”, Moscow, September, 2006.

213. Invited Presentation, First International Workshop on Myeloablative Chemotherapy and Hematopoietic Cell Rescue in Childhood Brain Tumors. “Is there a Role for myeloablative Chemotherapy in Malignant Gliomas of Childhood?, Milan, September 2006.

214. Invited Presentation, First International Workshop on Myeloablative Chemotherapy and Hematopoietic Cell Rescue in Childhood Brain Tumors. “Head Start” outcome for Non-disseminated Medulloblastoma”. Milan, September 2006.

215. Oncology Grand Rounds, Children’s Hospital Los Angeles. “Saving Lives, Saving Neurons: The Management of Young Children with Newly Diagnosed Malignant Brain Tumors”, Los Angeles, November 2006.

- 39 -

216. Invited Lecture, Xth Congress of Brazilian Pediatric Oncology. “Saving lives, Saving Neurons: The Management of Young Children with Newly Diagnosed Malignant Brain Tumors”, Salvador, Brazil, November 2006.

217. Invited Lecture, Xth Congress of Brazilian Pediatric Oncology. “The Future of Pediatric Neuro-oncology: An Array of Possibilities”. Salvador, Brazil, November 2006.

218. Oncology Grand Rounds, City of Hope Cancer Center, Duarte, California. “”Saving Lives, Saving Neurons: The Management of Young Children with Malignant Brain Tumors”. Duarte, California, January 2007.

219. Invited Speaker, Festschrift in Honor of Floyd Gilles MD, Pasadena, CA . “Controversies in the Diagnosis and Management of Primary CNS Germ Cell Tumors: A Historical Perspective”. Pasadena, California, March 16 th

2007.

220. Visiting Professor Lecture, Management of young Children with CNS Embryonal Tumors: 16 years of “Head Start” Irradiation-avoiding Strategies. The Hospital for Sick Children, Toronto, Canada, May 10th 2007.

221. Visiting Professor Neurosurgery Lecture: Current Controversies in the Diagnosis and Management of Primary CNS Germ Cell Tumors. The Hospital for Sick Children, Toronto, Canada, May 11th 2007.

222. Pediatric Oncology Seminar: Current Controversies in the Diagnosis and Management of Primary CNS Germ cell Tumors. The Hospital for Sick Children, Toronto, Canada, May 10th 2007

223. Pediatric Oncology Seminar: Current Controversies in the Diagnosis and Management of Primary CNS Germ cell Tumors. Division of Pediatric Hematology/Oncology, Korsair Children’s Hospital, University of Kentucky-Louisville. May 18th 2007.

224. Visiting Professor Lecture, Management of young Children with CNS Embryonal Tumors: 16 years of “Head Start” Irradiation-avoiding Strategies. Korsair Children’s Hospital, University of Kentucky-Louisville. May 18 th

2007.

225. Invited Lecture, 1st International Workshop of Pediatric Neuro-oncology. Diagnosis and Management of Medulloblastoma, Sao Paulo, Brazil, June 21st 2007.

226. Invited Lecture, 1st International Workshop of Pediatric Neuro-oncology. Management of Young Children with Malignant Brain Tumors. Sao Paulo, Brazil, June 22nd 2007.

227. Invited Lecture, 1st International Workshop of Pediatric Neuro-oncology. Controversies in the Diagnosis and Management of CNS Germ Cell Tumors. Sao Paulo, Brazil, June 22nd 2007.

228. Invited Lecture, 1st International Workshop of Pediatric Neuro-oncology. Malignant Gliomas of Childhood. Sao Paulo, Brazil, June 23rd 2007.

229. Invited Lecture, 5th Meeting of the Asian Society of Neuro-oncology. The Management of Children and Adults with Medulloblastoma and other PNET of the Brain. Istanbul, Turkey, November 3rd. 2007.

230. Invited Lecture, 5th Meeting of the Asian Society of Neuro-oncology. The Management of Young Children with Malignant Brain Tumors: Curative Strategies with Avoidance of Cranial Irradiation. Istanbul, Turkey, November 3rd. 2007

231. Invited Lecture, Pediatric Malignant Glioma Symposium, 12 th Annual Scientific Meeting of the Society of Neuro-oncology. Is there as role for myeloablative chemotherapy in the management of childhood malignant gliomas? Dallas, Texas. November 16th, 2007

232. Invited Seminar, Gene Therapeutics Program, Cedars-Sinai Medical Center. Progress in the management of young children with newly diagnosed medulloblastoma/PNET with irradiation-avoiding strategies. Los Angeles, California. January 7th 2008

- 40 -

233. Invited Lecture, 25th Anniversary Symposium of the Pediatric Cancer Research Foundation. Progress in the Management of Young Children with Malignant Brain Tumors. Anaheim, California. January 11th 2008.

234. Invited Seminar, Children’s Hospital of Oakland Oncology Journal Club. Childhood medulloblastoma, Oakland, California, March 12th 2008

235. Pediatric Grand Rounds, Children’s Hospital Los Angeles, Progress in the management of young children with malignant brain tumors. March 26th 2008

236. Invited Keynote address, 17th International Symposium on Brain Tumor Research & Therapy. Adult Medulloblastoma: Time for Change in Treatment Management. Hakodate, Hokkaido, Japan. June 12th 2008

237. Oral presentation, Pediatric Oncology in Developing Countries Mini-symposium, Annual Congress of the International Society of Paediatric Oncology (SIOP). Strategies for Managing Children with Brain Tumors in Developing Countries. Berlin, Germany. October 3rd 2008

238. Invited Lecture, Neuro-oncology Symposium, Italian Hospital. The Diagnosis and Management of Primary CNS Germ Cell Tumors. Buenos Aires, Argentina. November 6th 2008

239. Invited Lecture, Neuro-oncology Symposium, Italian Hospital. Adolescent and Adult Medulloblastoma: Time for a Change in Management. Buenos Aires, Argentina. November 6th 2008

240. Invited Lecture, Neuro-oncology Symposium, Italian Hospital. Saving Lives, saving Neurons: 17 years of irradiation-Avoiding Strategies in Malignant Brain Tumors of Young Children. Buenos Aires, Argentina. November 7th 2008

241. Invited Lecture, Neuro-oncology Symposium, Italian Hospital. Is there a Role for Myeloablative Chemotherapy Strategies in Children and Adults with Malignant Gliomas?. Buenos Aires, Argentina. November 7th 2008

242. Invited Lecture, XIth Annual SOBOPE Congress. Ependymoma in Younger Children. Gramado, Brazil. November 2008

243. Invited Lecture, XIth Annual SOBOPE Congress. Schering-Plough Satellite Symposium: Approaches to the Management of Malignant Gliomas of Childhood. Where are we going? Gramado, Brazil. November 2008

244. Invited Lecture, XIth Annual SOBOPE Congress. Adolescent and Adult Medulloblastoma: Time for a Change in Management. Gramado, Brazil. November 2008

245. Invited Lecture, XIth Annual SOBOPE Congress. Brain Cancer as Chronic Disease: The Management of Low Grade Gliomas of Childhood. Gramado, Brazil. November 2008

246. Invited Lecture, XIth Annual SOBOPE Congress. Recurrent Medulloblastoma: Role of Myeloablative Chemotherapy with Autologous Hematopoietic Cell Rescue. Gramado, Brazil. November 2008

247. Invited Lecture, XIth Annual SOBOPE Congress. An Overview of Childhood Brain Tumors. Gramado, Brazil. November 2008

248. Oncology Grand Rounds. Central Nervous System Germ Cell Tumors 2009: A Complicated Affair. Children’s Hospital Los Angeles. January 28th 2009.

249. Invited Speaker, International Outreach Program: The Management of Patients with Brain Tumors in Developing Countries: the Society of Neuro-oncology Initiative”. St. Jude Children’s Research Hospital, Memphis, Tennessee. February 5th 2009.

- 41 -

250. Invited Speaker, Brain Tumor Program: Myeloablative Chemotherapy with Autologous Hematopoietic Cell Rescue for Patients with Recurrent Medulloblastoma after Prior Irradiation: An Effective Modality? . St. Jude Children’s Research Hospital, Memphis, Tennessee. February 6th 2009.

251. Invited Seminar, Children’s Hospital of Oakland Oncology Journal Club. Management of Young Children with Malignant Brain Tumors. Oakland, California, February 13th 2009.

252. Invited Speaker, CNS Rhabdoid Tumors Joint Consensus Meeting: Irradiation-avoiding strategy for young children with CNS ATRT: An update of the “Head Start” I, II and III protocols. Boston, Massachusetts. March 10 th

2009.

253. Invited Speaker, 35th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT): Role of Marrow-ablative Chemotherapy in the Management of Childhood Brain Tumors. Goteborg, Sweden, March 30th 2009.

254. Keynote Address, 3rd Quadrennial Meeting of the World Federation of Neuro-oncology. Can we develop management strategies for adults and children with primary brain tumors in low-income countries? Yokohama, Japan, May 13th 2009

255. Keynote Address, 3rd Quadrennial Meeting of the World Federation of Neuro-oncology. Management of youngchildren newly-diagnosed with central nervous system (CNS) embryonal tumors: 18 years of three sequential

irradiation-avoiding chemotherapy studies-The “Head Start” Protocols. Yokohama, Japan, May 14th 2009

256. Invited lecture, Annual meeting of the Korean Society of Pediatric Neuro-oncology. Central Nervous System Germinoma 2009: A Complicated Affair. Seoul, South Korea, June 11th 2009

257. Invited Lecture, Annual Joint Meeting of the Korean Society of Pediatric Neuro-oncology and the Korean Cancer Society. Management of young children newly diagnosed with central nervous system(CNS) embryonal tumors: 18 years of three sequential irradiation-avoiding chemotherapy studies -The “Head Start” Protocols. Seoul, South Korea, June 11th 2009

258. Invited lecture, Samsung Medical Center and University Hospital. Myeloablative Chemotherapy with Autologous Hematopoietic Cell Rescue for Patients with Recurrent Medulloblastoma after Prior Irradiation: An Effective Modality? Seoul, South Korea, June 12th 2009

259. Invited Lecture, Instituto de Provision Sociale, Asunción, Paraguay. Childhood Brain Tumors: A 2009 Overview. Asunción, Paraguay, June 29th 2009

260. Invited Lecture, Neuro-oncology Congress, Clinica Davila, Santiago, Chile. Central Nervous SystemGerminoma 2009: A Complicated Affair. Santiago, Chile, September 3rd 2009

261. Invited Lecture, Neuro-oncology Congress, Clinica Davila, Santiago, Chile. Brain Cancer as ChronicDisease: The Management of Low Grade Gliomas of Childhood. Santiago, Chile, September 3rd 2009

262. Invited Lecture, Neuro-oncology Congress, Clinica Davila, Santiago, Chile. Adolescent and Adult Medulloblastoma: Time for Change in Treatment Management. Santiago, Chile, September 3rd 2009

263. Invited Lecture, Neuro-oncology Congress, Clinica Davila, Santiago, Chile. Brain Cancer as Chronic Disease: The Management of Low Grade Gliomas of Childhood. Santiago, Chile, September 4th 2009

264. Invited Lecture, 22nd Annual Congress of the Latin American Society of Pediatric Oncology (SLAOP), Sao Paolo, Brazil. Myeloablative chemotherapy and autologous hematopoietic cell rescue in Childhood Brain Tumors. Sao Paolo, Brazil, October 5th 2009

265. Invited Lecture, 22nd Annual Congress of the Latin American Society of Pediatric Oncology (SLAOP), Sao Paolo, Brazil. Management of Malignant Gliomas of Childhood. Sao Paolo, Brazil, October 5th 2009

- 42 -

266. Invited Lecture, 37th Annual Meeting of the International Society of Pediatric Neurosurgery, Pasadena, CA. Brain Tumors and Inheritable Cancer Predisposition Syndromes. Pasadena, California, October 13th

2009

267. Invited Speaker, Annual Meeting of the Central American Association of Pediatric Hematology-Oncology (AHOPCA), Nicaragua. Status of Management of Children with brain Cancer in Low IncomeCountries. Montelimar Beach, Nicaragua, February 19th 2010

268. Invited Speaker, City of Hope Cancer Center Neurosurgery Conference. Adolescent and Adult medulloblastoma: Time for a Change in Management? March 19th 2010

269. Invited Speaker, TUCCA Pediatric Oncology program, Santa Marcellina Hospital, Sao Paolo, Brazil.Management of young children newly diagnosed with central nervous system (CNS) embryonal tumors: 19years of three sequential irradiation-avoiding chemotherapy studies - The “Head Start” Protocols. Sao Paolo, Brazil, April 6th 2010

270. Invited Speaker, Dana Farber Cancer Center Bone Marrow Transplant Program. Recurrent Myeloablative Chemotherapy with Autologous Hematopoietic Cell Rescue for Patients with RecurrentMedulloblastoma after Prior Irradiation: An Effective Modality? Boston, Mass, April 15th 2010

271. Invited Speaker, Dana Farber Cancer Center Pediatric Neuro-oncology Program, Harvard University. Central Nervous System Germinoma 2010: A Complicated Affair. Boston, Mass, April 15th 2010

272. Invited Speaker, Dana Farber Cancer Center Pediatric Oncology Division, Harvard University. Management of young children newly diagnosed with central nervous system (CNS) embryonal tumors: 19years of three sequential irradiation-avoiding chemotherapy studies - The “Head Start” Protocols. Boston, Mass, April 15th 2010

273. Invited Speaker, Dana Farber Cancer Institute Neuro-oncology Program, Harvard University. Adolescent and Adult Medulloblastoma: Time for a Change in Management? Boston, Mass, April 16th 2010

274. Oncology Grand Rounds, Children’s Hospital Los Angeles. Inheritable conditions associated with Brain Tumors. Los Angeles, California, May 5th 2010

275. Invited Summation, South American Conference on Pediatric Neuro-oncology. Overview on the State of Management of Childhood Brain Tumors in Low Income Countries in Central and South America. Asuncion, Paraguay, August 17th 2010

276. Invited Seminar: “Management of Adolescents and Adults with medulloblastoma: Time for a Change in Strategy?” In: “Adolescent and Adult Medulloblastoma” Sunrise Session, annual meeting of the Society of Neuro-oncology, Montreal, Canada, November 21st 2010

277. Invited Lecture: “The Role of Marrow-ablative Chemotherapy in the Management of Children with Malignant Brain Tumors”. Annual Neuro-oncology Update, Huntsman Cancer Center, Salt Lake City, Utah. January 28th 2011

278. Invited Seminar: “The Outcome of the Head Start III Irradiation-Avoiding Chemotherapy Protocol, for Medulloblastoma and PNET”. SOBOPE (Brazilian Society of Pediatric Oncology) Workshop on Medulloblastoma/PNET. Sao Paolo, Brazil, February 14th 2011

279. Invited Seminar: “The Management of Adolescents and Adults with Medulloblastoma and PNET”. SOBOPE (Brazilian Society of Pediatric Oncology) Workshop on Medulloblastoma/PNET. Sao Paolo, Brazil, February 14 th

2011

280. Invited Speaker: “Childhood Brain Tumors: Progress….but no room for Complacency”. 25 th Regional Conference on Pediatric Hematology and Oncology Nursing, the Southern California Chapter of the Association of Pediatric Hematology Oncology Nurses (SCAPHON), Indian Wells, California, May 12th 2011

- 43 -

281.Invited Speaker: “Dose Intensification and The Allogeneic Effect: Overcoming Drug Resistance in Malignant Childhood Brain Tumors”, Sunrise Seminar Session, Pediatric Neuro-oncology Basic and Translational Research Conference, New Orleans, Louisiana, May 20th 2011

282. Invited Speaker: “Current Status of the Management of Young Children with Malignant Embryonal Tumors of the Central Nervous System: Results of the “Head Start III” Trial”. Oncology Grand Rounds, Children’s Hospital Los Angeles, June 1st 2011

283. Invited Speaker, Pediatrics Grand Rounds. “Rediscovering the Wheel: Old Strategies in new ways for malignant gliomas of childhood”. MD Anderson Cancer Center, Children’s Cancer Hospital, Houston, Texas, January 23rd 2012

284. Invited Speaker, Adult Neuro-oncology Conference. “Adult medulloblastoma –Time for a change in strategy?”.MD Anderson Cancer Center, Houston, Texas, January 23rd 2012

285. Invited Speaker, Pediatrics Grand Rounds. “From Autologous to Allogeneic Transplantation for Malignant Brain Tumors of Childhood?” Memorial Sloan-Kettering Cancer Center, New York, May 31st 2012

286. Invited Speaker, Cancer Predisposition Syndromes “Early Bird” session (with Drs. Stefan Pfister and Uri Tabori), 15th International Symposium on Pediatric Neuro-oncology, Toronto, Canada, June 27th 2012

287. Invited Speaker, University of Sao Paolo -Riberao Preto, Department of Pediatrics: “Current Status of the Management of Young Children with Malignant Embryonal Tumors of the Central Nervous System”, Riberao Preto, Minas Gerais, Brazil, August 23rd 2012

288. Invited Speaker, Federal University of Sao Paolo, Institute for Pediatric Oncology: “Current Status of the Management of Young Children with Malignant Embryonal Tumors of the Central Nervous System”, Sao Paolo, Brazil, August 29th 2012.

289. Invited Speaker, Santa Marcellina Hospital, Center for Pediatric Cancer: “Current Status of the Management of Young Children with Malignant Embryonal Tumors of the Central Nervous System”, Sao Paolo, Brazil, August 30 th

2012

290. Invited Speaker, Pavlove Symposium. Neuro-oncology Symposium, Children’s Hospital Los Angeles: “From Dream to reality: Improving the cure and quality of survival for young children newly-diagnosed with malignant brain tumors”. Los Angeles, California, Saturday, November 13th 2012

291. Invited Speaker, 1st International Neuro-oncology Course, 12th Uruguayan Congress of Oncology: “Medulloblastoma in Adolescents and Adults”. Montevideo, Uruguay, November 21st 2012

292. Invited Speaker, 1st International Neuro-oncology Course, 12th Uruguayan Congress of Oncology: “The management of Children with Malignant gliomas”. Montevideo, Uruguay, November 21st 2012

293. Invited Speaker, Pereira Rossell Children’s Hospital, Universidad de la Republica, Pediatric Oncology Program: “From Dream to Reality: The Management of Young Children with Malignant brain Tumors with Irradiation-avoiding Strategies”. Montevideo, Uruguay, November 22nd 2012

294. Invited Speaker, 24th Congress of the Latin American Society of Pediatric Oncology, Bogota, Colombia: “CNS Germ Cell Tumors, 2013: Germinoma, A Complicated Affair”. Bogota, Colombia, April 3rd 2013

295. Invited Speaker, 24th Congress of the Latin American Society of Pediatric Oncology, Bogota, Colombia: “From Dream to reality: Improved Survival and Quality of Survival for Young Children with Malignant Brain Tumors”. Bogota, Colombia, April 4th 2013

- 44 -

296. Invited Speaker, Cell and Gene Therapy Program, Department of Pediatrics, Texas Children’s Hospital and Baylor University, Houston, Texas: “Overcoming Treatment resistance in Malignant brain tumors: From Autologous to Allogeneic HCT after Marrow-ablative Chemotherapy - and beyond”. Houston, Texas, May 7th 2013

297. Invited Speaker, Division of Pediatric Hematology-Oncology & Bone Marrow Transplantation, Department of Pediatrics, Westchester County Medical Center & The Maria Petrie Children’s Hospital, Valhalla, New York: “Overcoming Treatment resistance in Malignant Brain Tumors: From Autologous to Allogeneic HCT after Marrow-ablative Chemotherapy - and beyond”. Valhalla, New York, August 9th 2013

298. Oncology Grand Rounds, Children’s Hospital Los Angeles. “Marrow-ablative Chemotherapy for Childhood and Adolescent Malignant Brain Tumors - From Autologous to Allogeneic Hematopoietic Cell Transplantation….. and Beyond”. October 2nd 2013

299. Invited Speaker, Pediatric Neuro-oncology Workshop, GRAACC Children’s Cancer Institute, Sao Paolo, Brasil. “Management Strategies for Childhood CNS Germinomas” Monday December 10th 2013

300. Invited Speaker, Pediatric Neuro-oncology Workshop, GRAACC Children’s Cancer Institute, Sao Paolo, Brazil. “Management Strategies for Newly-Diagnosed Childhood Medulloblastoma” Monday December 10th 2013

301. Invited Seminar, Nationwide Children’s Hospital, Columbus, Ohio. “Marrow-ablative Chemotherapy for Childhood and Adolescent Malignant Brain Tumors - From Autologous to Allogeneic Hematopoietic Cell Transplantation - and Beyond”. January 7th 2014

302. Invited Seminar, Invited Speaker, University of Sao Paolo – Riberao Preto, Department of Pediatrics: “New Approaches to the Management of Medulloblastoma”, Riberao Preto, Minas Gerais, Brazil, September 7th 2014

303. Invited Seminar, Invited Speaker, University of Sao Paolo - Riberao Preto, Department of Pediatrics: “Inheritable Conditions Predisposing to Brain Cancer”, Riberao Preto, Minas Gerais, Brazil, September 7th 2014

304. Invited Speaker, Pediatric Grand Rounds, Children’s Hospital of Michigan: “Evolving Strategies in the Management of Young Children with Malignant Brain Tumors”, Friday, March 6th 2015

305. Invited Speaker, Satellite Symposium on Pediatric Brain Tumors, 4th International CNS Germ Cell Tumor Symposium: “Ependymoma”, Tokyo, Japan, April 15th 2015

306. Invited Speaker, Satellite Symposium on Pediatric Brain Tumors, 4th International CNS Germ Cell Tumor Symposium: “High-Grade Gliomas”, Tokyo, Japan, April 15th 2015

307. Invited Speaker, Satellite Symposium on Pediatric Brain Tumors, 4th International CNS Germ Cell Tumor Symposium: “Summation and Take Home Pivotal Points”, Tokyo, Japan, April 15th 2015

308. Keynote Presentation, Annual Conference of the British Neuro-oncology Society: “Adolescent and Adult Medulloblastoma: Time for a Change in Management Strategy”. Nottingham, UK, July 2nd 2015

309. Presentation, Pediatric Latin American Neuro-oncology (PLANO) Symposium: “Pediatric Neuro-oncology Global Heath Initiative in Columbus and Sao Paolo”. Sao Paolo, Brazil, August 31st 2015

310. Presentation, Pediatric Latin American Neuro-oncology (PLANO) Symposium: “State of the Art Management of Children with Medulloblastoma”. Sao Paolo, Brazil, August 31st 2015

311. Presentation, Pediatric Latin American Neuro-oncology (PLANO) Symposium: “State of the Art Management of Children with High-grade Gliomas”. Sao Paolo, Brazil, August 31st 2015

312. Presentation, Pediatric Latin American Neuro-oncology (PLANO) Symposium: “State of the Art Management of Children with Ependymomas”. Sao Paolo, Brazil, September 1st 2015

- 45 -

313. Presentation, International Ependymoma Workshop: “Management of Supratentorial Ependymoma in the Current Molecular Era”, Ontario, Canada, September 20th 2015

314. Invited Lecture, Kanti Children’s Hospital, Kathmandu, Nepal: “Diagnosis and Management of Childhood Brain Tumors: 2015 Global Perspective”, November 6h 2015

315. Invited Lecture, Nepali Neurology & Neurosurgery Society, Kathmandu, Nepal: “Diagnosis and Management of Childhood Brain Tumors: 2015 Global Perspective”, November 7th 2015

Ohio (Loco-Regional) Seminars/Lectures/Presentations: July 1 st 2014+ :

1. Invited presentation to the Chairman, Nationwide Insurance: “Innovative Brain Tumor Proposals at Nationwide Children’s Hospital” October 2014.

2. Presentation, the Ohio Clinical Trials Collaborative (OCTC) Neuro-oncology Meeting: “Proposal for OCTC-wide phase II/feasibility trial of GemPOx and myelo-ablative chemotherapy for children, adolescents and adults with recurrent CNS germ cell tumors”, September 2014

3. Invited Speaker, Ohio State University Brain Tumor Seminar Series: “Management of Adult Medulloblastoma –Time for a Change in Strategy”, October 14th 2014

4. Invited Speaker, Nationwide Children’s Hospital Translational Research in Hem/Onc/BMT series: “Primary Central Nervous System (CNS) Germ Cell Tumors -– Lessons from and for the Management of Extra-CNS Germ Cell Tumors”, October 31st 2014

5. Invited Speaker, Nationwide Children’s Hospital “Lounge & Learn” Seminar series: “HeadSmart, HeadStart and Other Innovations in the Management of Childhood Brain Cancer”, Friday, February 6th 2015

6. Invited presentation, the Community Pediatric Practice Board: Strategy to Improve the Time to Diagnosis of Children and Adolescents with Brain Cancer in Ohio”, Nationwide Children’s Hospital, Thursday, February 12 th

2015

7. Invited Speaker, Nationwide Children’s Hospital Neurology Seminar Series: “HeadSmart, HeadStart and Other Innovations in the Management of Childhood Brain Cancer”, Thursday, March 12th 2015

8. Invited Speaker, Nationwide Children’s Hospital Pediatric Hematology/Oncology Fellows Seminar Series: “CNS Tumors of Children, Adolescents and Young Adults 101. Part 1: Introduction and Medulloblastoma”, Tuesday March 17th 2015

9. Invited Speaker, Nationwide Children’s Hospital Pediatric Hematology/Oncology Fellows Seminar Series: “CNS Tumors of Children, Adolescents and Young Adults 101. Part 2: Ependymoma”, Tuesday March 31st 2015

10. Pediatric Grand Rounds, Nationwide Children’s Hospital: “Inheritable Conditions Predisposing to Brain Cancer” Thursday, April 23rd 2015

11. Presentation, the Ohio Clinical Trials Collaborative (OCTC) Neuro-oncology meeting: “Feasibility Pilot Study of ‘GemPOx’ followed by Marrow-ablative Chemotherapy for Recurrent CNS Germ Cell Tumors”, Nationwide Children’s Hospital, Monday April 27th 2015

12. Presentation, Genetic Predisposition to Brain Cancer Symposium: “Overview to Inheritable Conditions Predisposing to Brain Cancer”, Columbus, OH, May 11th 2015

13. Presentation, Genetic Predisposition to Brain Cancer Symposium - Family Symposium: “Overview to Inheritable Conditions Predisposing to Brain Cancer”, Columbus, OH, May 11th 2015

- 46 -

14. Presentation, Bench to Outcome Seminar Series (with Dr. Christopher Pierson): “Young Children with Medulloblastoma”, Nationwide Children’s Hospital, Columbus, OH, July 7th 2015

15. Lecture, Ohio Cancer Registrars Association (OCRA). “Childhood Brain Tumors 101: A 2015 Overview”., Lewis Center, Ohio, September 17th 2015

16. Lecture, 2015 Fall Cancer Symposium: Pediatric and Adult Neuro-oncology Updates. Promedica Cancer Institute, Sylvania, Ohio, Thursday October 1st 2015

17. Presentation, Nationwide Children’s Hospital Neuro-oncology Seminar Series: “Supratentorial Ependymoma in the Molecular Era”, Monday, October 13th 2015

18. Presentation (x 3), Nationwide Children’s Hospital Affiliation Summit Conference; “Early identification and treatment of Brain Cancer”. Wednesday, October 28th 2015

19. Seminar, Pediatric Hematology, Oncology and BMT Division; “Nepal – Pediatric Healthcare in a low-Income Developing Country”, Friday, December 18th 2015

20. Presentation, 2nd Ohio State University Neuro-oncology Program retreat. Overview of Nationwide Children’s Hospital Neuro-oncology Program Clinical/Translational Studies. January 13th 2016

21. Presentation, Nationwide Children’s Hospital Neuro-oncology Seminar Series: Management of Pediatric High-grade Gliomas”. Monday, January 25th 2016

- 47 -

cv part a february 2016

Documents